##fileformat=VCFv4.2
##fileDate=2024-02-08
##reference=GRCh38
##INFO=<ID=bayesdel,Number=1,Type=String,Description="Missense variant functional predictions by BayesDel tool (Feng 2017) used without allele frequency. Score bigger or equal to 0.16: damaging; Score smaller than 0.16: tolerated. Scores were imported from dbNSFP. (version: 4.4, version date: 2023-05-06 )">
##INFO=<ID=cadd_scaled,Number=1,Type=String,Description="The scaled CADD scores: PHRED-like (-10*log10(rank/total)) scaled C-score ranking a variant relative to all possible substitutions of the human genome (8.6x10^9). These scores range from 1 to 99. A cutoff for deleteriousness can be set to 10-15, but the choice remains arbitrary. (version: v1.6, version date: 2020-04-11 )">
##INFO=<ID=cancerhotspots_ac,Number=1,Type=String,Description="Number of samples showing the variant from cancerhotspots (version: v2, version date: 2017-12-15 )">
##INFO=<ID=cancerhotspots_af,Number=1,Type=String,Description="Allele Frequency of the variant (AC / num samples cancerhotspots) (version: v2, version date: 2017-12-15 )">
##INFO=<ID=cancerhotspots_cancertypes,Number=1,Type=String,Description="A | delimited list of all cancertypes associated to this variant according to cancerhotspots. FORMAT: tumortype:tissue (version: v2, version date: 2017-12-15 )">
##INFO=<ID=clinvar,Number=1,Type=String,Description="The Variation ID from ClinVar (version: -, version date: 2023-02-26 )">
##INFO=<ID=clinvar_submissions,Number=.,Type=String,Description="An & separated list of clinvar submissions. Format:interpretation|last_evaluated|review_status|submission_condition|submitter|comment">
##INFO=<ID=clinvar_summary,Number=.,Type=String,Description="summary of the clinvar submissions. FORMAT: review_status:interpretation_summary">
##INFO=<ID=consensus_classification,Number=1,Type=String,Description="The recent consensus classification by the VUS-task-force. Format: consensus_class|consensus_comment|submission_date|consensus_scheme|consensus_scheme_class|consensus_criteria_string. The consensus criteria string itself is a $ separated list with the Format: criterium_name+criterium_strength+criterium_evidence+is_selecteds ">
##INFO=<ID=consequences,Number=.,Type=String,Description="An & separated list of variant consequences from vep. Format:Transcript|hgvsc|hgvsp,consequence|impact|exonnr|intronnr|genesymbol|proteindomain|isgencodebasic|ismaneselect|ismaneplusclinical|isensemblcanonical|transcript_biotype|transcript_length">
##INFO=<ID=cosmic,Number=1,Type=String,Description="The COSV ID from COSMIC (version: -, version date: 2023-06-06 )">
##INFO=<ID=gnomad_ac,Number=1,Type=String,Description="gnomAD alternate allele count for samples (version: v3.1.2, version date: 2021-10-22 )">
##INFO=<ID=gnomad_af,Number=1,Type=String,Description="gnomAD frequency of alternate allele in samples (version: v3.1.2, version date: 2021-10-22 )">
##INFO=<ID=gnomad_het,Number=1,Type=String,Description="gnomAD number of heterozygous individuals in samples (version: v3.1.2, version date: 2021-10-22 )">
##INFO=<ID=gnomad_hom,Number=1,Type=String,Description="gnomAD number of homozygous individuals in samples (version: v3.1.2, version date: 2021-10-22 )">
##INFO=<ID=gnomad_popmax,Number=1,Type=String,Description="gnomAD population with maximum allele frequency (AF) (version: v3.1.2, version date: 2021-10-22 )">
##INFO=<ID=gnomad_popmax_AC,Number=1,Type=String,Description="The allele count from the popmax population from GnomAD (version: v3.1.2, version date: 2021-10-22 )">
##INFO=<ID=gnomad_popmax_AF,Number=1,Type=String,Description="The allele frequency of the "popmax" population (version: v3.1.2, version date: 2021-10-22 )">
##INFO=<ID=heredicare_annotation,Number=.,Type=String,Description="An & separated list of the variant annotations from heredicare. Format:vid|n_fam|n_pat|vustf_selected_class|vustf_comment|vustf_classification_date. n_fam is the number of families having the variant and n_pat is the number of individuals having the variant.">
##INFO=<ID=heredicare_vid,Number=1,Type=String,Description="The VID from HerediCare.The version_date is inaccurate. They are always up to date when reimporting from heredicare. (version: -, version date: 2023-01-01 )">
##INFO=<ID=hexplorer,Number=1,Type=String,Description="The HEXplorer delta score (HZEI mutant - HZEI wildtype). HZEI scores were normalized by the total number of nucleotide positions which contribute to the score. (version: 1.0, version date: 2022-06-30 )">
##INFO=<ID=hexplorer_mut,Number=1,Type=String,Description="The HEXplorer score for the mutant sequence. HZEI scores were normalized by the total number of nucleotide positions which contribute to the score. (version: 1.0, version date: 2022-06-30 )">
##INFO=<ID=hexplorer_rev,Number=1,Type=String,Description="The HEXplorer delta score for the reverse complement of the original sequence (HZEI mutant rev - HZEI wildtype rev). HZEI scores were normalized by the total number of nucleotide positions which contribute to the score. (version: 1.0, version date: 2022-06-30 )">
##INFO=<ID=hexplorer_rev_mut,Number=1,Type=String,Description="The HEXplorer score for the reverse complement of the mutant sequence. HZEI scores were normalized by the total number of nucleotide positions which contribute to the score. (version: 1.0, version date: 2022-06-30 )">
##INFO=<ID=hexplorer_rev_wt,Number=1,Type=String,Description="The HEXplorer score for the reverse complement of the reference sequence. HZEI scores were normalized by the total number of nucleotide positions which contribute to the score. (version: 1.0, version date: 2022-06-30 )">
##INFO=<ID=hexplorer_wt,Number=1,Type=String,Description="The HEXplorer score for the reference sequence. HZEI scores were normalized by the total number of nucleotide positions which contribute to the score. (version: 1.0, version date: 2022-06-30 )">
##INFO=<ID=max_hbond,Number=1,Type=String,Description="The HBond delta score (max HBond mutant - max HBond wildtype). This score shows the change in binding affinity of the U1 snRNA to the splice site motiv, i. e. its ability to form hbonds with the sequence motiv. Negative values show that the mutant sequence is less probable to bind the U1 snRNA (This is a "worse" binding site). Positive values mean that the mutant sequence is more likely to bind the U1 snRNA. If there are multiple possible splice sites only the max values are considered. (version: 1.0, version date: 2022-06-30 )">
##INFO=<ID=max_hbond_mut,Number=1,Type=String,Description="The max HBond score for the mutant sequence.  (version: 1.0, version date: 2022-06-30 )">
##INFO=<ID=max_hbond_rev,Number=1,Type=String,Description="The max HBond delta score for the reverse complement of the original sequence (HZEI mutant rev - HZEI wildtype rev). This score shows the change in binding affinity of the U1 snRNA to the splice site motiv, i. e. its ability to form hbonds with the sequence motiv. Negative values show that the mutant sequence is less probable to bind the U1 snRNA (This is a "worse" binding site). Positive values mean that the mutant sequence is more likely to bind the U1 snRNA. If there are multiple possible splice sites only the max values are considered. (version: 1.0, version date: 2022-06-30 )">
##INFO=<ID=max_hbond_rev_mut,Number=1,Type=String,Description="This is the max HBond score for the reverse complement of the mutant sequence. (version: 1.0, version date: 2022-06-30 )">
##INFO=<ID=max_hbond_rev_wt,Number=1,Type=String,Description="This is the max HBond score for the reverse complement of the reference sequence. (version: 1.0, version date: 2022-06-30 )">
##INFO=<ID=max_hbond_wt,Number=1,Type=String,Description="This is the max HBond score for the reference sequence. (version: 1.0, version date: 2022-06-30 )">
##INFO=<ID=maxentscan,Number=1,Type=String,Description="The transcript specific MaxEntScan scores calculated from ngs-bits. Each value is of the form: ref|alt. A | separated list of transcript$value pairs. (version: v1.0.0, version date: 2023-09-27 )">
##INFO=<ID=maxentscan_alt,Number=1,Type=String,Description="MaxEntScan alternate sequence score calculated though VEP release-104.3 using the MaxEntScan plugin (version: -, version date: 2018-08-29 )">
##INFO=<ID=maxentscan_ref,Number=1,Type=String,Description="MaxEntScan reference sequence score. The lower the score, the more difference one would expect the input (ie mutated) sequence is from the reference. Whenever the difference between ref and alt is positive it predicts a functional splice site. A negative difference predicts that this position is not a functional splice site. (version: -, version date: 2018-08-29 )">
##INFO=<ID=maxentscan_swa,Number=1,Type=String,Description="The transcript specific MaxEntScan SWA scores calculated from ngs-bits. A special application of the MaxEntScan algorithm to discover de-novo spliceing variants. Each value is of the form maxentscan_ref_donor|maxentscan_alt_donor|maxentscan_donor_comp|maxentscan_ref_acceptor|maxentscan_alt_acceptor|maxentscan_acceptor_comp. A | separated list of transcript$value pairs. (version: v1.0.0, version date: 2023-09-27 )">
##INFO=<ID=phylop_100way,Number=1,Type=String,Description="PhyloP 100 vertebrates (100-way) conservation scores. These scores measure evolutionary conservation at individual alignment sites. Interpretations of the scores are compared to the evolution that is expected under neutral drift. Positive scores: Measure conservation, which is slower evolution than expected, at sites that are predicted to be conserved. Negative scores: Measure acceleration, which is faster evolution than expected, at sites that are predicted to be fast-evolving.  (version: -, version date: 2013-12-01 )">
##INFO=<ID=pubmed,Number=.,Type=String,Description="An & separated list of pubmed ids relevant for this variant.">
##INFO=<ID=revel,Number=1,Type=String,Description="The REVEL pathogenicity score of this variant. This score can range from 0 to 1, which reflects the number of trees in the random forest that classified the variant as pathogenic. Thus, higher values represent a more "certain" decision. When choosing a cutoff one should keep in mind that higher cutoffs will result in a higher specificity, but lower sensitivity.. A | separated list of transcript$value pairs. (version: v1.3, version date: 2021-05-03 )">
##INFO=<ID=rsid,Number=1,Type=String,Description="The rs-number of a variant from dbSNP (version summary: https://www.ncbi.nlm.nih.gov/projects/SNP/snp_summary.cgi) (version: 155, version date: 2021-06-16 )">
##INFO=<ID=spliceai_details,Number=1,Type=String,Description="Details about the SpliceAI predictions: These include delta scores (DS) and delta positions (DP) for acceptor gain (AG), acceptor loss (AL), donor gain (DG), and donor loss (DL). Format: GENE|DS_AG|DS_AL|DS_DG|DS_DL|DP_AG|DP_AL|DP_DG|DP_DL (version: v1.3.1, version date: 2021-09-07 )">
##INFO=<ID=spliceai_max_delta,Number=1,Type=String,Description="Max of delta scores for acceptor gain, acceptor loss, donor gain and donor loss. A value of 0.5 or more can be assumed to have an impact on splicing. (version: v1.3.1, version date: 2021-09-07 )">
##INFO=<ID=task_force_protein_domain,Number=1,Type=String,Description="The description of the protein domain from a hand-crafted table by the VUS-Task-Force. (version: -, version date: 2022-06-01 )">
##INFO=<ID=task_force_protein_domain_source,Number=1,Type=String,Description="The source of the task force protein domain. (version: -, version date: 2022-06-01 )">
##INFO=<ID=user_classification,Number=1,Type=String,Description="The recent consensus classification by the VUS-task-force. Format: consensus_class|consensus_comment|submission_date|consensus_scheme|consensus_scheme_class|consensus_criteria_string. The consensus criteria string itself is a $ separated list with the Format: criterium_name+criterium_strength+criterium_evidence+is_selecteds ">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO
chr2	47783306	18845	G	T	.	.	phylop_100way=-0.036;cadd_scaled=3.944;revel=ENST00000234420$0.076|ENST00000446255$0.076|ENST00000540021$0.076|ENST00000544857$0.076;spliceai_details=MSH6%7C0.00%7C0.00%7C0.00%7C0.00%7C5%7C23%7C18%7C-1;spliceai_max_delta=0.0;maxentscan_swa=ENST00000234420$-3.98%7C-12.15%7C-15.44%7C-2.66%7C-1.87%7C-2.66|ENST00000540021$-3.98%7C-12.15%7C-15.44%7C-2.66%7C-1.87%7C-2.66|ENST00000652107$-3.98%7C-12.15%7C-15.44%7C-2.66%7C-1.87%7C-2.66|ENST00000673637$-3.98%7C-12.15%7C-15.44%7C-2.66%7C-1.87%7C-2.66|ENST00000700000$-3.98%7C-12.15%7C-15.44%7C-2.66%7C-1.87%7C-2.66|ENST00000700002$-3.98%7C-12.15%7C-15.44%7C-2.66%7C-1.87%7C-2.66|ENST00000700004$-3.98%7C-12.15%7C-15.44%7C-2.66%7C-1.87%7C-2.66;gnomad_ac=32;gnomad_af=0.000210283;gnomad_hom=0;gnomad_het=32;gnomad_popmax=NFE;gnomad_popmax_AF=0.000396930;gnomad_popmax_AC=27;hexplorer=1.59;hexplorer_mut=1.67;hexplorer_wt=0.08;hexplorer_rev=4.70;hexplorer_rev_mut=9.26;hexplorer_rev_wt=4.56;max_hbond=1.80;max_hbond_mut=1.80;bayesdel=-0.402036;heredicare_vid=11252670;rsid=267608026;clinvar=89562;user_classification=2|BP4,_BS1,_BS3|2023-11-08_15:05:27|ACMG_standard|2|BP4+supporting_benign+REVEL:0.076+1$BS1+supporting_benign+popmax:NFE_popmax_AF:0.000396930+1$BS3+supporting_benign+PMID:_28531214_+1|26517685+whereas_risk-variant_Chr2:48010445:G_>_T,_with_predicted_change_MSH6:p.(Ala25Ser),_which_could_be_in_linkage_with_the_familial_mutation,_occurred_in_subject_12–04-079_32_having_a_neutral_clinical_phenotype.$28531214+The_other_5_variants_in_the_clinical_cohort,_A25S,_E221D,_G670R,_R922Q_and_c.3438%2B6T>C,_were_not_identified_as_MMR_abrogating.&2|BP4,_BP6,_BS1|2023-11-10_09:43:51|ACMG_standard|2|BP4+supporting_benign+PubMed:_18566915‚_19924528‚_22102614‚_26517685‚_28531214‚_28767289‚_34445333‚_35904628+1$BP6+supporting_benign+It_is_classified_with_3_stars_in_ClinVar_as_VUS_by_an_expert_panel_(InSiGHT)_and_U_Wash,_and_as_Likely_benign_by_GeneDx,_Invitae,_and_Ambry._+1$BS1+strong_benign+The_observed_variant_frequency_within_Non-Finnish_European_control_individuals_in_the_gnomAD_database_is_approximately_2-fold_of_the_estimated_maximal_expected_allele_frequency_for_a_pathogenic_variant_in_MSH6_causing_Hereditary_Nonpolyposis_Colorectal_Cancer_phenotype+1|&2|Zusatzhinweis:_Co-occurrence_with_another_potentially_pathogenic_variant_has_been_reported_at_least_twice_(MSH6_c.2926_2929dupCGTT_in_Jori_2015_and_MSH6_c.3103C>T/p.Arg1035X_internal_testing),_providing_supporting_evidence_for_a_benign_role.|2023-11-10_13:04:12|ACMG_standard|1|BP4+supporting_benign+In_Sillico:_benign+1$BS1+strong_benign+AF:_0.0002799_(non-cancer)+1$BS3+supporting_benign+At_least_two_independent_publications_report_experimental_evidence_that_the_variant_does_not_affect_normal_function_of_MSH6_(e.g._Drost_2011,_Houlleberghs_2017)._+1|&2|Zusatzhinweis:_Co-occurrence_with_another_potentially_pathogenic_variant_has_been_reported_at_least_twice_(MSH6_c.2926_2929dupCGTT_in_Jori_2015_and_MSH6_c.3103C>T/p.Arg1035X_internal_testing),_providing_supporting_evidence_for_a_benign_role.|2023-11-10_10:56:06|No_scheme|-||&2|BS3,_BS1_supp,_BP4,_BP2|2023-11-10_11:04:02|ACMG_standard|2|BP2+supporting_benign+PMID:_26517685:_in_Pat._12–04-079_32_variant_co-segregate_with_the_MSH6_familial_mutation_c.2926_2929dupCGTT_carried_by_this_subject,_patient_with_endometrium_cancer_and_no_other_tumors+1$BP4+supporting_benign+REVEL:_0.076+1$BS1+supporting_benign+FAF%1Y0.02%+1$BS3+strong_benign+PMID:_28531214:_not_identified_as_MMR_abrogating_PMID:_22102614:_In_vitro_MMR_%2B+1|&2|BP4_BS1_BS3|2023-11-11_14:58:18|ACMG_standard|2|BP4+supporting_benign+BP4+1$BS1+supporting_benign+BS1+1$BS3+supporting_benign+BS3+1|&2|BP4,_BS3,_evtl._BS1|2023-11-12_11:40:29|ACMG_standard|2|BP4+supporting_benign+BP4+1$BS3+strong_benign+BP3_-_wie_gut_sind_diese_studies?,_Evtl_noch_BS1_dazu.+1|&2|none|2023-11-13_16:45:01|ACMG_standard|2|BP4+supporting_benign+Computational_Evidence_that_no_impact_on_gene_function:_CADD_(v1.6):_Phred:_3.944,_Raw_score:_0.270453._More_details._REVEL_(v2021-05-03):_Score:_0.076._More_details._Align_GVGD_(v2007):_Class_C0_(GV:_353.86_-_GD:_0.00)._More_details._PolyPhen2_(v):_HDivPred:_benign_(score:_0.041)._HVarPred:_benign_(score:_0.007)._More_details._SIFT_(v6.2.0):_TOLERATED_(score:_0.55,_median:_3.76)._More_details._MutationTaster_(v2021):_Benign._Tree_vote:_3%7C97_(del%7Cbenign)._More_details.+1$BS1+supporting_benign+gnomAD/ClinVar:_The_observed_variant_frequency_(0.029268%)_within_Non-Finnish_European_control_individuals_in_the_gnomAD_database_is_approximately_2-fold_of_the_estimated_maximal_expected_allele_frequency_for_a_pathogenic_variant_in_MSH6_causing_Hereditary_Nonpolyposis_Colorectal_Cancer_phenotype_(0.00014),_strongly_suggesting_that_the_variant_is_a_benign_polymorphism_found_primarily_in_populations_of_Non-Finnish_European_origin_(ClinVar,_+1$BS3+supporting_benign+functional_study_shows_no_loss_of_functionality:__Houlleberghs_H_et_al.,_2017%3B_Drost_et_al.,_2012_+1|22102614+A_rapid_and_cell-free_assay_to_test_the_activity_of_lynch_syndrome-associated_MSH2_and_MSH6_missense_variants>_Fig._2,_Fig.3,_table_1_>proficient$28531214+The_other_5_variants_in_the_clinical_cohort,_A25S,_E221D,_G670R,_R922Q_and_c.3438_%2B6T>C,_were_not_identified_as_MMR_abrogating._VUS_E221D,_G670R_and_R922Q_were_found_in_patients_who_also_harbored_a_second,_known_pathogenic_mutation_in_one_of_the_DNA_MMR_genes_that_was_likely_causative_for_the_LS_phenotype._E221D_was_also_detected_in_a_second_patient_who_was_83_years_old_and_did_not_have_a_family_history_suspicious_for_LS._MSH6-A25S_was_found_in_a_typical_LS_tumor,_i.e.,_a_colon_tumor_showing_MSI,_loss_of_heterozygosity_of_MSH6,_and_loss_of_MSH6_protein_expression._The_patient_however_only_had_one_relative_with_a_colorectal_tumor_and_this_tumor_was_not_MSI-high_and_stained_positive_for_all_MMR_proteins._A_previous_in_vitro_study_also_suggested_MSH6-A25S_is_not_pathogenic_[45]%3B_it_could_be_that_the_tumor_arose_due_to_a_missed_somatic_mutation&2|Frederiksen_et_al.,_2021%3B_Houlleberghs_et_al.,_2017%3B|2023-11-14_09:51:36|ACMG_standard|2|BP4+supporting_benign+->_REVEL,_COPD+1$BS3+supporting_benign+Frederiksen_et_al.,_2021%3B_Houlleberghs_et_al.,_2017+1|&2|BP4,_BS3|2023-11-14_09:59:51|ACMG_standard|2|BP4+supporting_benign+in_silico_unauff.+1$BS3+strong_benign+Drost_2011,_Houlleberghs_2017+1|;consensus_classification=2|REVEL:_0.076_(BP4),_approximately_2-fold_of_the_estimated_maximal_expected_allele_(BS1_sup),_BS3,_PMID:_28531214:_not_identified_as_MMR_abrogating|2023-11-14_10:48:37|ACMG_standard|2|BP4+supporting_benign+REVEL:_0.076_(BP4),__+1$BS1+supporting_benign+The_observed_variant_frequency_within_Non-Finnish_European_control_individuals_in_the_gnomAD_database_is_approximately_2-fold_of_the_estimated_maximal_expected_allele_frequency_for_a_pathogenic_variant_in_MSH6_causing_Hereditary_Nonpolyposis_Colorectal_Cancer_phenotype+1$BS3+strong_benign+PMID:_28531214:_not_identified_as_MMR_abrogating_PMID:_22102614:_In_vitro_MMR_%2B+1|;clinvar_summary=criteria_provided,_conflicting_interpretations:Conflicting_interpretations_of_pathogenicity%7CUncertain_significance(3)%7CLikely_benign(9);clinvar_submissions=Likely_benign|2021-05-19|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Sema4,_Sema4|None&Uncertain_significance|2015-11-20|criteria_provided,_single_submitter|C4552100:Lynch_syndrome|University_of_Washington_Department_of_Laboratory_Medicine,_University_of_Washington|None&Likely_benign|2023-06-05|criteria_provided,_single_submitter|CN169374:not_specified|Women's_Health_and_Genetics/Laboratory_Corporation_of_America,_LabCorp|description:_Variant_summary:_MSH6_c.73G>T_(p.Ala25Ser)_results_in_a_conservative_amino_acid_change_in_the_encoded_protein_sequence._Five_of_five_in-silico_tools_predict_a_benign_effect_of_the_variant_on_protein_function._The_variant_allele_was_found_at_a_frequency_of_0.00014_in_242354_control_chromosomes,_predominantly_at_a_frequency_of_0.00029_within_the_Non-Finnish_European_subpopulation_in_the_gnomAD_database._The_observed_variant_frequency_within_Non-Finnish_European_control_individuals_in_the_gnomAD_database_is_approximately_2-fold_of_the_estimated_maximal_expected_allele_frequency_for_a_pathogenic_variant_in_MSH6_causing_Hereditary_Nonpolyposis_Colorectal_Cancer_phenotype_(0.00014),_strongly_suggesting_that_the_variant_is_a_benign_polymorphism_found_primarily_in_populations_of_Non-Finnish_European_origin._c.73G>T_has_been_reported_in_the_literature_in_individuals_evaluated_for_Hereditary_Nonpolyposis_Colorectal_Cancer_(e.g._Nilbert_2009,_Jori_2015,_Houlleberghs_2017)._These_reports_do_not_provide_unequivocal_conclusions_about_association_of_the_variant_with_Hereditary_Nonpolyposis_Colorectal_Cancer._Co-occurrence_with_another_potentially_pathogenic_variant_has_been_reported_at_least_twice_(MSH6_c.2926_2929dupCGTT_in_Jori_2015_and_MSH6_c.3103C>T/p.Arg1035X_internal_testing),_providing_supporting_evidence_for_a_benign_role._The_variant_has_also_been_reported_in_individuals_with_other_cancer_phenotypes_(e.g._Wasielewski_2009,_Shindo_2017)_and_healthy_controls_(e.g._Wasielewski_2009)._At_least_two_independent_publications_report_experimental_evidence_that_the_variant_does_not_affect_normal_function_of_MSH6_(e.g._Drost_2011,_Houlleberghs_2017)._The_following_publications_have_been_ascertained_in_the_context_of_this_evaluation_(PMID:_35904628,_22102614,_34445333,_28531214,_26517685,_18566915,_28767289,_19924528)._Eleven_other_submitters_have_provided_clinical-significance_assessments_for_this_variant_in_ClinVar_after_2014_without_evidence_for_independent_evaluation,_and_classified_the_variant_as_VUS_(n%1Y3)_or_likely_benign_(n%1Y8)._Based_on_the_evidence_outlined_above,_the_variant_was_classified_as_likely_benign.&Likely_benign|2023-08-15|criteria_provided,_single_submitter|CN169374:not_specified|Center_for_Genomic_Medicine,_Rigshospitalet,_Copenhagen_University_Hospital|None&Likely_benign|2018-09-10|criteria_provided,_single_submitter|C3661900:not_provided|Quest_Diagnostics_Nichols_Institute_San_Juan_Capistrano|None&Likely_benign|2020-02-06|criteria_provided,_single_submitter|CN169374:not_specified|Genetic_Services_Laboratory,_University_of_Chicago|None&Uncertain_significance|2018-10-31|criteria_provided,_single_submitter|C0476089:Endometrial_carcinoma$C1833477:Lynch_syndrome_5$C5399763:Turcot_syndrome|Fulgent_Genetics,_Fulgent_Genetics|None&Likely_benign|2019-01-16|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Ambry_Genetics|description:_This_alteration_is_classified_as_likely_benign_based_on_a_combination_of_the_following:_population_frequency,_intact_protein_function,_lack_of_segregation_with_disease,_co-occurrence,_RNA_analysis,_in_silico_models,_amino_acid_conservation,_lack_of_disease_association_in_case-control_studies,_and/or_the_mechanism_of_disease_or_impacted_region_is_inconsistent_with_a_known_cause_of_pathogenicity.&Likely_benign|2017-09-14|criteria_provided,_single_submitter|CN169374:not_specified|GeneDx|description:_This_variant_is_considered_likely_benign_or_benign_based_on_one_or_more_of_the_following_criteria:_it_is_a_conservative_change,_it_occurs_at_a_poorly_conserved_position_in_the_protein,_it_is_predicted_to_be_benign_by_multiple_in_silico_algorithms,_and/or_has_population_frequency_not_consistent_with_disease.&Likely_benign|2015-04-07|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Color_Diagnostics,_LLC_DBA_Color_Health|None&Likely_benign|2022-10-11|criteria_provided,_single_submitter|C0009405:Hereditary_nonpolyposis_colorectal_neoplasms|Invitae|None&Uncertain_significance|2017-01-25|criteria_provided,_single_submitter|CN169374:not_specified|Laboratory_for_Molecular_Medicine,_Mass_General_Brigham_Personalized_Medicine|description:_Variant_identified_in_a_genome_or_exome_case(s)_and_assessed_due_to_predicted_null_impact_of_the_variant_or_pathogenic_assertions_in_the_literature_or_databases._Disclaimer:_This_variant_has_not_undergone_full_assessment._The_following_are_preliminary_notes:_This_variant_has_been_reported_in_HGMD,_classified_as_DM?._It_has_been_seen_in_2_breast_cancer_families._In_one_in_vitro_study_the_variant_was_shown_to_be_mismatch_repair_proficient._In_another_paper_it_is_predicted_to_be_neutral._The_variant_has_a_Max_MAF_of_0.03%_in_ExAC_(16_alleles)_and_0.03%_in_gnomAD_(35_alleles)._It_is_classified_with_3_stars_in_ClinVar_as_VUS_by_an_expert_panel_(InSiGHT)_and_U_Wash,_and_as_Likely_benign_by_GeneDx,_Invitae,_and_Ambry._This_region_is_not_conserved_and_2_mammals_have_a_Ser_at_this_position.;heredicare_annotation=11252670|30|31|||;consequences=ENST00000234420|c.73G>T|p.Ala25Ser|missense_variant|moderate|1|None|MSH6|None|True|True|False|True|protein_coding|4073&ENST00000411819|None|None|upstream_gene_variant|modifier|None|None|MSH6|None|True|False|False|False|protein_coding|3777&ENST00000420813|None|None|upstream_gene_variant|modifier|None|None|MSH6|None|True|False|False|False|protein_coding|3777&ENST00000445503|c.73G>T|p.Ala25Ser|missense_variant_%26_NMD_transcript_variant|moderate|1|None|MSH6|None|False|False|False|False|nonsense_mediated_decay|480&ENST00000455383|None|None|upstream_gene_variant|modifier|None|None|MSH6|None|True|False|False|False|protein_coding|3777&ENST00000456246|c.73G>T|p.Ala25Ser|missense_variant_%26_NMD_transcript_variant|moderate|1|None|MSH6|None|False|False|False|False|nonsense_mediated_decay|313&ENST00000493177|n.137G>T|None|non_coding_transcript_exon_variant|modifier|1|None|MSH6|None|False|False|False|False|protein_coding_CDS_not_defined|811&ENST00000540021|c.73G>T|p.Ala25Ser|missense_variant|moderate|1|None|MSH6|None|True|False|False|False|protein_coding|3685&ENST00000636749|None|None|downstream_gene_variant|modifier|None|None|None|None|False|False|False|False|None|None&ENST00000652107|c.-37-7621G>T|None|intron_variant|modifier|None|3|MSH6|None|True|False|False|False|protein_coding|3777&ENST00000673637|c.-38%2B75G>T|None|intron_variant|modifier|None|1|MSH6|None|True|False|False|False|protein_coding|3777&ENST00000673922|n.162G>T|None|non_coding_transcript_exon_variant|modifier|1|None|MSH6|None|False|False|False|False|protein_coding_CDS_not_defined|571&ENST00000699999|n.157G>T|None|non_coding_transcript_exon_variant|modifier|1|None|MSH6|None|False|False|False|False|retained_intron|4813&ENST00000700000|c.73G>T|p.Ala25Ser|missense_variant|moderate|1|None|MSH6|None|True|False|False|False|protein_coding|2507&ENST00000700001|n.145G>T|None|non_coding_transcript_exon_variant|modifier|1|None|MSH6|None|False|False|False|False|retained_intron|3056&ENST00000700002|c.73G>T|p.Ala25Ser|missense_variant|moderate|1|None|MSH6|None|True|False|False|False|protein_coding|4079&ENST00000700003|c.73G>T|p.Ala25Ser|missense_variant_%26_NMD_transcript_variant|moderate|1|None|MSH6|None|False|False|False|False|nonsense_mediated_decay|686&ENSR00000116858|None|None|regulatory_region_variant|modifier|None|None|None|None|False|False|False|False|None|None&ENSM00524773590|None|None|TF_binding_site_variant|modifier|None|None|None|None|False|False|False|False|None|None&NM_000179|c.73G>T|p.Ala25Ser|missense_variant|moderate|1|None|MSH6|None|True|True|False|True|mRNA|4073&NM_001281492|c.73G>T|p.Ala25Ser|missense_variant|moderate|1|None|MSH6|None|True|False|False|False|mRNA|3685&NM_001281493|c.-664G>T|None|5_prime_UTR_variant|modifier|1|None|MSH6|None|False|False|False|False|mRNA|3170&NM_001281494|None|None|upstream_gene_variant|modifier|None|None|MSH6|None|False|False|False|False|mRNA|3170&XM_024452819|c.73G>T|p.Ala25Ser|missense_variant|moderate|1|None|MSH6|None|False|False|False|False|None|None&XM_024452820|None|None|upstream_gene_variant|modifier|None|None|MSH6|None|False|False|False|False|None|None&XM_024452821|None|None|upstream_gene_variant|modifier|None|None|MSH6|None|False|False|False|False|None|None&XM_024452822|c.-664G>T|None|5_prime_UTR_variant|modifier|1|None|MSH6|None|False|False|False|False|None|None;literature=25741868&24033266&26845104&26206375&22290698&26333163&18566915&26517685&19924528&22102614&28767289&28531214&30787465&23621914&28944238&28569743&29684080&26659599&26743474&28466842&29641532
chr17	35107366	184	C	T	.	.	phylop_100way=5.477;cadd_scaled=25.2;spliceai_details=RAD51D%7C0.00%7C0.00%7C0.12%7C0.90%7C17%7C25%7C17%7C0,RAD51L3-RFFL%7C0.00%7C0.00%7C0.12%7C0.00%7C17%7C25%7C17%7C0;spliceai_max_delta=0.9,0.12;maxentscan=ENST00000345365$7.79%7C1.99|ENST00000394589$7.79%7C1.99|ENST00000586186$7.79%7C1.99|ENST00000590016$7.79%7C1.99;maxentscan_swa=ENST00000335858$7.79%7C1.99%7C7.79%7C-5.27%7C-7.89%7C-8.40|ENST00000345365$7.79%7C1.99%7C7.79%7C-5.27%7C-7.89%7C-8.40|ENST00000394589$7.79%7C1.99%7C7.79%7C-5.27%7C-7.89%7C-8.40|ENST00000460118$7.79%7C1.99%7C7.79%7C-5.27%7C-7.89%7C-8.40|ENST00000586186$7.79%7C1.99%7C7.79%7C-5.27%7C-7.89%7C-8.40|ENST00000587405$7.79%7C1.99%7C7.79%7C-5.27%7C-7.89%7C-8.40|ENST00000590016$7.79%7C1.99%7C7.79%7C-5.27%7C-7.89%7C-8.40|ENST00000592577$7.79%7C1.99%7C7.79%7C-5.27%7C-7.89%7C-8.40;task_force_protein_domain=ATPase_domain_and_RAD51B,_RAD51C,_and_XRCC2_binding;task_force_protein_domain_source=BWRL_(PMID_10749867,_14704354,_19327148);hexplorer=-5.42;hexplorer_mut=-6.32;hexplorer_wt=-0.90;hexplorer_rev=4.44;hexplorer_rev_mut=2.93;hexplorer_rev_wt=-1.51;max_hbond=0.00;max_hbond_mut=9.30;max_hbond_wt=9.30;max_hbond_rev=-4.70;max_hbond_rev_mut=9.30;max_hbond_rev_wt=14.00;rsid=1555568469;heredicare_vid=16653266;clinvar=492426;cosmic=COSV100238899;user_classification=3|class_3_(PM2_supporting,_PP3)|2023-06-09_08:27:45|ACMG_standard|3|PM2+medium_pathogenic+PM2_supporting+1$PP3+supporting_pathogenic+PP3_(splice_predictions)+1|&3|instead_of_expected_Frameshift_(Class_3_Tendenz_4)|2023-06-12_09:09:07|ACMG_standard|3|PM2+medium_pathogenic+not_in_gnomAD+1$PP3+supporting_pathogenic+varSEAK:_Class_5_use_of_crypric_splice_site_35_nt_downstream_Splice_AI:_0,92+1|&3%2B|Quantitative_RNA-Analyse_notwendig,_Effekt_der_Isoformen_unklar.|2023-07-14_11:54:40|ACMG_standard|4|PS3+strong_pathogenic+Eigene_RNA-Analysen_(79721):_Die_Sequenzen_der_WT-Bande_und_der_Isoform_D3_(Bande_3)_von_der_Patientin_zeigen,_dass_diese_monoallelisch_durch_das_WT-Allel_exprimiert_werden._Die_Isoformen_D4_(Bande_2)_und_D3%2B4_(Bande_4)_zeigen_im_Gelbild_eine_stärkere_Expression_im_Vergleich_zu_den_Referenzen._Eine_enhanced_skipping_von_Exon_4_durch_die_Variante_lässt_sich_daher_vermuten._Eine_genaue_Quantifizierung_konnte_hier_nicht_vorgenommen_werden._+1$PM2+medium_pathogenic+not_in_gnomAD+1$PP3+supporting_pathogenic+Splice_prediction_auffällig+1|;consensus_classification=3|Own_splice_analysis_not_quantitative._Quantitative_splice_analysis_and_segregation_data_needed.|2024-01-08_13:28:11|ACMG_standard|4|PS3+strong_pathogenic+Enhanced_skipping_of_exon_4_in_RNA-analysis._Quantification_not_possible.+1$PM2+supporting_pathogenic+not_in_gnomAD+1$PP3+supporting_pathogenic+PP3_(spliceAI:_RAD51D:_0.9)+1|;clinvar_summary=criteria_provided,_multiple_submitters,_no_conflicts:Uncertain_significance;clinvar_submissions=Uncertain_significance|2019-04-03|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Color_Diagnostics,_LLC_DBA_Color_Health|None&Uncertain_significance|2021-06-10|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Ambry_Genetics|description:_The_c.345G>A_variant_(also_known_as_p.Q115Q),_located_in_coding_exon_4_of_the_RAD51D_gene,_results_from_a_G_to_A_substitution_at_nucleotide_position_345._This_nucleotide_substitution_does_not_change_the_amino_acid_at_codon_115._However,_this_change_occurs_in_the_last_base_pair_of_coding_exon_4,_which_makes_it_likely_to_have_some_effect_on_normal_mRNA_splicing._This_nucleotide_position_is_highly_conserved_in_available_vertebrate_species._In_silico_splice_site_analysis_predicts_that_this_alteration_will_weaken_the_native_splice_donor_site._Internal_RNA_studies_as_well_as_in_the_literature_have_shown_that_exons_3_through_5_are_excluded_in_several_naturally_occurring_RAD51D_transcripts_(Davy_G_et_al._Eur._J._Hum._Genet.,_2017_10%3B25:1147-1154%3B_Ambry_internal_data)._Since_supporting_evidence_is_limited_at_this_time,_the_clinical_significance_of_this_alteration_remains_unclear.;heredicare_annotation=16653266|1|1|34|Exons_3_through_5_are_excluded_in_several_naturally_occurring_RAD51D_transcripts_(Davy_G_et_al._Eur._J._Hum._Genet.,_2017_10%3B25:1147-1154%3B_PMID:_28905878_Ambry_internal_dataQuantitative_RNA-Analyse_notwendigPM2_supp,_PP3_((PM2_supp,_PS3_mod,_PM4)|2023-06-13;consequences=ENST00000335858|c.145-885G>A|None|intron_variant|modifier|None|2|RAD51D|None|True|False|False|False|protein_coding|644&ENST00000345365|c.345G>A|p.Gln115%1Y|splice_region_variant_%26_synonymous_variant|low|4|None|RAD51D|PF08423|True|True|False|True|protein_coding|977&ENST00000394589|c.345G>A|p.Gln115%1Y|splice_region_variant_%26_synonymous_variant|low|5|None|RAD51D|PF08423|True|False|False|False|protein_coding|977&ENST00000415064|n.495G>A|None|splice_region_variant_%26_non_coding_transcript_exon_variant|low|4|None|RAD51D|None|False|False|False|False|protein_coding_CDS_not_defined|978&ENST00000460118|c.-126G>A|None|splice_region_variant_%26_5_prime_UTR_variant|low|3|None|RAD51D|None|True|False|False|False|protein_coding|451&ENST00000585343|c.*167G>A|None|splice_region_variant_%26_3_prime_UTR_variant_%26_NMD_transcript_variant|low|4|None|RAD51D|None|False|False|False|False|nonsense_mediated_decay|257&ENST00000585947|n.241G>A|None|splice_region_variant_%26_non_coding_transcript_exon_variant|low|2|None|RAD51D|None|False|False|False|False|retained_intron|668&ENST00000585982|n.500G>A|None|splice_region_variant_%26_non_coding_transcript_exon_variant|low|4|None|RAD51D|None|False|False|False|False|protein_coding_CDS_not_defined|591&ENST00000586044|c.*76G>A|None|splice_region_variant_%26_3_prime_UTR_variant_%26_NMD_transcript_variant|low|3|None|RAD51D|None|False|False|False|False|nonsense_mediated_decay|147&ENST00000586186|c.249G>A|p.Gln83%1Y|splice_region_variant_%26_synonymous_variant|low|3|None|RAD51D|PF08423|True|False|False|False|protein_coding|843&ENST00000586210|c.264-244G>A|None|intron_variant_%26_NMD_transcript_variant|modifier|None|3|RAD51D|None|False|False|False|False|nonsense_mediated_decay|320&ENST00000587405|c.-13G>A|None|splice_region_variant_%26_5_prime_UTR_variant|low|2|None|RAD51D|None|True|False|False|False|protein_coding|624&ENST00000587977|c.*86-244G>A|None|intron_variant_%26_NMD_transcript_variant|modifier|None|4|RAD51D|None|False|False|False|False|nonsense_mediated_decay|353&ENST00000587982|n.273G>A|None|splice_region_variant_%26_non_coding_transcript_exon_variant|low|2|None|RAD51D|None|False|False|False|False|protein_coding_CDS_not_defined|678&ENST00000588372|c.-13G>A|None|splice_region_variant_%26_5_prime_UTR_variant_%26_NMD_transcript_variant|low|2|None|RAD51D|None|False|False|False|False|nonsense_mediated_decay|279&ENST00000588594|c.*76G>A|None|splice_region_variant_%26_3_prime_UTR_variant_%26_NMD_transcript_variant|low|3|None|RAD51D|None|False|False|False|False|nonsense_mediated_decay|147&ENST00000589506|n.437G>A|None|non_coding_transcript_exon_variant|modifier|3|None|RAD51D|None|False|False|False|False|retained_intron|561&ENST00000590016|c.405G>A|p.Gln135%1Y|splice_region_variant_%26_synonymous_variant|low|4|None|RAD51D|PF08423|True|False|False|False|protein_coding|1037&ENST00000590631|c.-51-885G>A|None|intron_variant|modifier|None|1|RAD51D|None|False|False|False|False|retained_intron|558&ENST00000592430|n.314G>A|None|splice_region_variant_%26_non_coding_transcript_exon_variant|low|2|None|RAD51D|None|False|False|False|False|protein_coding_CDS_not_defined|693&ENST00000592577|c.351G>A|p.Gln117%1Y|splice_region_variant_%26_synonymous_variant|low|4|None|RAD51D|PF08423|True|False|False|False|protein_coding|624&ENST00000592850|c.*86-885G>A|None|intron_variant_%26_NMD_transcript_variant|modifier|None|3|RAD51D|None|False|False|False|False|nonsense_mediated_decay|257&ENST00000592928|n.167-885G>A|None|intron_variant_%26_non_coding_transcript_variant|modifier|None|2|RAD51D|None|False|False|False|False|protein_coding_CDS_not_defined|204&ENSR00001008778|None|None|regulatory_region_variant|modifier|None|None|None|None|False|False|False|False|None|None&NM_001142571|c.405G>A|p.Gln135%1Y|splice_region_variant_%26_synonymous_variant|low|4|None|RAD51D|None|True|False|False|False|mRNA|1037&NM_002878|c.345G>A|p.Gln115%1Y|splice_region_variant_%26_synonymous_variant|low|4|None|RAD51D|None|True|True|False|True|mRNA|977&NM_133629|c.145-885G>A|None|intron_variant|modifier|None|2|RAD51D|None|True|False|False|False|mRNA|644&NR_037711|n.371G>A|None|splice_region_variant_%26_non_coding_transcript_exon_variant|low|3|None|RAD51D|None|False|False|False|False|misc_RNA|9736&NR_037712|n.371G>A|None|splice_region_variant_%26_non_coding_transcript_exon_variant|low|3|None|RAD51D|None|False|False|False|False|misc_RNA|9602&NR_037714|n.233-885G>A|None|intron_variant_%26_non_coding_transcript_variant|modifier|None|1|None|None|False|False|False|False|None|None;literature=9536098&21822267&17576681
chr17	35119612	212	A	C	.	.	phylop_100way=5.879;cadd_scaled=27.0;revel=ENST00000335858$0.524|ENST00000345365$0.524|ENST00000345766$0.524|ENST00000357906$0.524|ENST00000360276$0.524|ENST00000394589$0.524|ENST00000418935$0.524;spliceai_details=RAD51D%7C0.00%7C0.00%7C0.00%7C0.00%7C-1%7C-13%7C-1%7C-2,RAD51L3-RFFL%7C0.02%7C0.00%7C0.00%7C0.00%7C-1%7C-13%7C-1%7C-13;spliceai_max_delta=0.0,0.02;maxentscan_swa=ENST00000335858$-2.55%7C2.09%7C-2.55%7C1.63%7C1.74%7C-6.86|ENST00000345365$-2.55%7C2.09%7C-2.55%7C1.63%7C1.74%7C-6.86|ENST00000394589$-2.55%7C2.09%7C-2.55%7C1.63%7C1.74%7C-6.86|ENST00000460118$-2.55%7C2.09%7C-2.55%7C1.63%7C1.74%7C-6.86|ENST00000586186$-2.55%7C2.09%7C-2.55%7C1.63%7C1.74%7C-6.86|ENST00000587405$-2.55%7C2.09%7C-2.55%7C1.63%7C1.74%7C-6.86|ENST00000590016$-2.55%7C2.09%7C-2.55%7C1.63%7C1.74%7C-6.86|ENST00000592577$-2.55%7C2.09%7C-2.55%7C1.63%7C1.74%7C-6.86;task_force_protein_domain=N-terminal_region;task_force_protein_domain_source=BWRL_https://www.sciencedirect.com/science/article/abs/pii/S1357272510003924;hexplorer=-2.04;hexplorer_mut=-2.76;hexplorer_wt=-0.72;hexplorer_rev=-4.28;hexplorer_rev_mut=-2.78;hexplorer_rev_wt=1.50;max_hbond=-2.10;max_hbond_mut=1.80;max_hbond_wt=3.90;bayesdel=0.63;rsid=1064794619;clinvar=420660;heredicare_vid=9792591;user_classification=3%2B|Class_3_Tendenz_4|2023-07-07_09:34:17|VUS-task-force_standard|3|3.2+supporting_benign+Class_3_Tendenz_4_(Die_Variante_liegt_in_N-Terminal_Region_des_RAD51D_(AA_1-83),_wo_bisher_keine_pathologische_Missense-Mutationen_beschrieben_wurden._Durch_Veränderung_c.2T>G_wird_höchtswahrscheinlich_das_Start-Codon_komplett_ausfalllen_oder_es_wir_ein_alternatives_Start-Codon_15_AS_später_gebildet._Funktionelle_Daten_fehlen).__+1|&4|class_4|2023-07-10_11:37:30|ACMG_standard|4|PS1+strong_pathogenic+RAD51D_c.2dup_p.Met1?_als_Kl.4*_von_VUS-TF_vom_20.09.2022_Begründung:_Mögliches_alternatives_in_frame_Startcodon_an_AS-Position_16._Aber_weitere_pathogene_Varianten_in_den_ersten_15_AS_auch_bei_OC_beschrieben,_daher_Class_4!_siehe_Bewertungen_in_ClinVar_und_andere_Varianten_in_RAD51D_welche_das_Startcodon_betreffen_in_HGMD/ClinVar:_c.2T>A%3B__c.1A>T,_c.1A>G_(alle_p.Met1?)_als_DM/LP/P+1$PM2+supporting_pathogenic+absent_from_controls_+1$PP5+supporting_pathogenic+ClinVar:_1xVUS_2021,_1xLP_2016,_1xP_2022_(Ambry)+1|;consensus_classification=4|Initiation_codon_variant,_Class_4|2024-01-05_14:19:41|ACMG_standard|5|PVS1+very_strong_pathogenic+Initiation_codon+1$PS1+medium_pathogenic+Additional_variants_affecting_the_start_codon_also_classified_as_class_4/5._Possible_alternative_start_codon_at_position_16_but_pathogenic_variants_in_first_15_aa_described_in_ovarian_cancer_patients_in_ClinVar+1$PM2+supporting_pathogenic+absent_from_controls_+1|;clinvar_summary=criteria_provided,_conflicting_interpretations:Conflicting_interpretations_of_pathogenicity%7CPathogenic(1)%7CLikely_pathogenic(1)%7CUncertain_significance(1);clinvar_submissions=Uncertain_significance|2021-07-15|criteria_provided,_single_submitter|C3280345:Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Invitae|description:_This_sequence_change_affects_the_initiator_methionine_of_the_RAD51D_mRNA._The_next_in-frame_methionine_is_located_at_codon_16._This_variant_is_not_present_in_population_databases_(ExAC_no_frequency)._Disruption_of_the_initiator_codon_has_been_observed_in_individual(s)_with_breast,_ovarian,_and/or_colorectal_cancer_(PMID:_24130102,_26681312,_30322717)._ClinVar_contains_an_entry_for_this_variant_(Variation_ID:_420660)._Experimental_studies_and_prediction_algorithms_are_not_available_or_were_not_evaluated,_and_the_functional_significance_of_this_variant_is_currently_unknown._RNA_analysis_indicates_that_this_variant_does_not_impact_mRNA_splicing_(PMID:_24130102)._In_summary,_the_available_evidence_is_currently_insufficient_to_determine_the_role_of_this_variant_in_disease._Therefore,_it_has_been_classified_as_a_Variant_of_Uncertain_Significance.&Likely_pathogenic|2016-03-21|criteria_provided,_single_submitter|C3661900:not_provided|GeneDx|description:_This_variant_alters_the_initiator_Methionine_codon,_and_the_resultant_protein_would_be_described_as_Â“p.Met1?Â”_to_signify_that_it_is_not_known_if_the_loss_of_Met1_prevents_all_protein_translation_or_if_an_abnormal_protein_is_produced_using_an_alternate_Methionine_codon._RAD51D_c.2T>G_has_not_been_previously_published_as_a_pathogenic_variant,_nor_has_it_been_reported_as_a_benign_polymorphism_to_our_knowledge._However,_the_adjacent_variant_RAD51D_c.1A>T,_which_also_results_in_p.Met1?,_has_been_reported_in_an_individual_with_a_personal_history_of_both_breast_and_ovarian_cancer_(Gutierrez-Enriquez_2014)._As_RAD51D_c.2T>G_is_predicted_to_alter_normal_protein_production,_it_is_considered_a_likely_pathogenic_variant.&Pathogenic|2022-01-27|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Ambry_Genetics|description:_The_p.M1?_pathogenic_mutation_(also_known_as_c.2T>G)_is_located_in_coding_exon_1_of_the_RAD51D_gene_and_results_from_a_T_to_G_substitution_at_nucleotide_position_2._This_alters_the_methionine_residue_at_the_initiation_codon_(ATG)._This_amino_acid_position_is_highly_conserved_in_available_vertebrate_species._Sequence_variations_that_modify_the_initiation_codon_are_expected_to_result_in_either_loss_of_translation_initiation,_N-terminal_truncation,_or_cause_a_shift_in_the_mRNA_reading_frame._Based_on_the_supporting_evidence,_this_alteration_is_interpreted_as_a_disease-causing_mutation.;heredicare_annotation=9792591|2|2|14|PVS1,_PM2_supp,_PM5?_(c.1A>T_schon_pathogen_beschrieben,_Gutierrez-Enriquez_2014)Alle_Varianten_die_das_Startcodon_betreffen_neu_bewerten!!!!|2023-07-11;consequences=ENST00000158009|None|None|upstream_gene_variant|modifier|None|None|FNDC8|None|True|True|False|True|protein_coding|971&ENST00000335858|c.2T>G|p.Met1?|start_lost|high|1|None|RAD51D|None|True|False|False|False|protein_coding|644&ENST00000345365|c.2T>G|p.Met1?|start_lost|high|1|None|RAD51D|None|True|True|False|True|protein_coding|977&ENST00000394589|c.2T>G|p.Met1?|start_lost|high|2|None|RAD51D|None|True|False|False|False|protein_coding|977&ENST00000415064|n.233-440T>G|None|intron_variant_%26_non_coding_transcript_variant|modifier|None|1|RAD51D|None|False|False|False|False|protein_coding_CDS_not_defined|978&ENST00000460118|c.-350T>G|None|5_prime_UTR_variant|modifier|1|None|RAD51D|None|True|False|False|False|protein_coding|451&ENST00000585343|None|None|upstream_gene_variant|modifier|None|None|RAD51D|None|False|False|False|False|nonsense_mediated_decay|257&ENST00000585947|n.159%2B1679T>G|None|intron_variant_%26_non_coding_transcript_variant|modifier|None|1|RAD51D|None|False|False|False|False|retained_intron|668&ENST00000585982|n.178-440T>G|None|intron_variant_%26_non_coding_transcript_variant|modifier|None|1|RAD51D|None|False|False|False|False|protein_coding_CDS_not_defined|591&ENST00000586044|c.2T>G|p.Met1?|start_lost_%26_NMD_transcript_variant|high|1|None|RAD51D|None|False|False|False|False|nonsense_mediated_decay|147&ENST00000586186|None|None|upstream_gene_variant|modifier|None|None|RAD51D|None|True|False|False|False|protein_coding|843&ENST00000586210|c.2T>G|p.Met1?|start_lost_%26_NMD_transcript_variant|high|1|None|RAD51D|None|False|False|False|False|nonsense_mediated_decay|320&ENST00000587405|c.-95%2B1679T>G|None|intron_variant|modifier|None|1|RAD51D|None|True|False|False|False|protein_coding|624&ENST00000587977|c.2T>G|p.Met1?|start_lost_%26_NMD_transcript_variant|high|1|None|RAD51D|None|False|False|False|False|nonsense_mediated_decay|353&ENST00000587982|n.191%2B1679T>G|None|intron_variant_%26_non_coding_transcript_variant|modifier|None|1|RAD51D|None|False|False|False|False|protein_coding_CDS_not_defined|678&ENST00000588372|c.-95%2B1679T>G|None|intron_variant_%26_NMD_transcript_variant|modifier|None|1|RAD51D|None|False|False|False|False|nonsense_mediated_decay|279&ENST00000588594|c.2T>G|p.Met1?|start_lost_%26_NMD_transcript_variant|high|1|None|RAD51D|None|False|False|False|False|nonsense_mediated_decay|147&ENST00000589506|n.213T>G|None|non_coding_transcript_exon_variant|modifier|1|None|RAD51D|None|False|False|False|False|retained_intron|561&ENST00000590016|c.2T>G|p.Met1?|start_lost|high|1|None|RAD51D|None|True|False|False|False|protein_coding|1037&ENST00000590631|None|None|upstream_gene_variant|modifier|None|None|RAD51D|None|False|False|False|False|retained_intron|558&ENST00000592430|n.232%2B1679T>G|None|intron_variant_%26_non_coding_transcript_variant|modifier|None|1|RAD51D|None|False|False|False|False|protein_coding_CDS_not_defined|693&ENST00000592577|c.88%2B88T>G|None|intron_variant|modifier|None|1|RAD51D|None|True|False|False|False|protein_coding|624&ENST00000592850|None|None|upstream_gene_variant|modifier|None|None|RAD51D|None|False|False|False|False|nonsense_mediated_decay|257&ENST00000592928|None|None|upstream_gene_variant|modifier|None|None|RAD51D|None|False|False|False|False|protein_coding_CDS_not_defined|204&ENSR00000093447|None|None|regulatory_region_variant|modifier|None|None|None|None|False|False|False|False|None|None&ENSM00195651931|None|None|TF_binding_site_variant|modifier|None|None|None|None|False|False|False|False|None|None&ENSM00523612603|None|None|TF_binding_site_variant|modifier|None|None|None|None|False|False|False|False|None|None&NM_001142571|c.2T>G|p.Met1?|start_lost|high|1|None|RAD51D|None|True|False|False|False|mRNA|1037&NM_002878|c.2T>G|p.Met1?|start_lost|high|1|None|RAD51D|None|True|True|False|True|mRNA|977&NM_017559|None|None|upstream_gene_variant|modifier|None|None|FNDC8|None|True|True|False|True|mRNA|971&NM_133629|c.2T>G|p.Met1?|start_lost|high|1|None|RAD51D|None|True|False|False|False|mRNA|644&NR_037711|n.147T>G|None|non_coding_transcript_exon_variant|modifier|1|None|RAD51D|None|False|False|False|False|misc_RNA|9736&NR_037712|n.147T>G|None|non_coding_transcript_exon_variant|modifier|1|None|RAD51D|None|False|False|False|False|misc_RNA|9602&NR_037714|n.232%2B1679T>G|None|intron_variant_%26_non_coding_transcript_variant|modifier|None|1|None|None|False|False|False|False|None|None;literature=32359370
chr2	47799279	6730	T	G	.	.	phylop_100way=0.881;cadd_scaled=23.8;revel=ENST00000234420$0.891|ENST00000538136$0.891|ENST00000540021$0.891|ENST00000544857$0.891;spliceai_details=MSH6%7C0.00%7C0.00%7C0.00%7C0.00%7C-50%7C-11%7C-1%7C-12;spliceai_max_delta=0.0;maxentscan_swa=ENST00000234420$-5.84%7C-0.09%7C-8.59%7C-5.47%7C-6.30%7C-5.47|ENST00000405808$-15.21%7C-14.89%7C-15.32%7C-3.13%7C-2.26%7C-3.13|ENST00000411819$-5.84%7C-0.09%7C-8.59%7C-5.47%7C-6.30%7C-5.47|ENST00000420813$-5.84%7C-0.09%7C-8.59%7C-5.47%7C-6.30%7C-5.47|ENST00000455383$-5.84%7C-0.09%7C-8.59%7C-5.47%7C-6.30%7C-5.47|ENST00000540021$-5.84%7C-0.09%7C-8.59%7C-5.47%7C-6.30%7C-5.47|ENST00000652107$-5.84%7C-0.09%7C-8.59%7C-5.47%7C-6.30%7C-5.47|ENST00000673637$-5.84%7C-0.09%7C-8.59%7C-5.47%7C-6.30%7C-5.47|ENST00000700000$-5.84%7C-0.09%7C-8.59%7C-5.47%7C-6.30%7C-5.47|ENST00000700002$-5.84%7C-0.09%7C-8.59%7C-5.47%7C-6.30%7C-5.47|ENST00000700004$-5.84%7C-0.09%7C-8.59%7C-5.47%7C-6.30%7C-5.47;task_force_protein_domain=DNA_mismatch_/MMR_binding_domain;task_force_protein_domain_source=PMID:_23391514%3BPMID:_28765196;hexplorer=7.32;hexplorer_mut=-2.78;hexplorer_wt=-10.10;hexplorer_rev=6.64;hexplorer_rev_mut=-3.12;hexplorer_rev_wt=-9.77;max_hbond=8.70;max_hbond_mut=8.70;bayesdel=0.445891;heredicare_vid=13068850;clinvar=216294;rsid=863224614;clinvar_summary=criteria_provided,_conflicting_interpretations:Conflicting_interpretations_of_pathogenicity%7CLikely_pathogenic(2)%7CUncertain_significance(2);clinvar_submissions=Uncertain_significance|2015-08-25|criteria_provided,_single_submitter|C4552100:Lynch_syndrome|Invitae|description:_This_sequence_change_replaces_phenylalanine_with_leucine_at_codon_432_of_the_MSH6_protein_(p.Phe432Leu)._The_phenylalanine_residue_is_highly_conserved_and_there_is_a_small_physicochemical_difference_between_phenylalanine_and_leucine._This_variant_has_not_been_published_in_the_literature_as_a_germline_variant_and_is_not_present_in_population_databases._A_different_missense_variant_involving_the_same_codon_(p.Phe432Ser)_has_been_reported_in_an_affected_individual_with_endometrial_cancer_(PMID:_24933100)._Algorithms_developed_to_predict_the_effect_of_missense_changes_on_protein_structure_and_function_do_not_agree_on_the_potential_impact_of_this_missense_change_(SIFT:_"Deleterious"%3B_PolyPhen-2:_"Probably_Damaging"%3B_Align-GVGD:_"Class_C15")._However,_an_algorithm_developed_specifically_for_the_MSH6_suggests_that_this_variant_is_likely_to_be_disruptive_(PMID:_23621914),_but_these_predictions_have_not_been_confirmed_by_published_functional_studies._In_summary,_this_is_a_novel_missense_change_with_uncertain_impact_on_protein_function._It_has_been_classified_as_a_Variant_of_Uncertain_Significance.&Uncertain_significance|2021-08-31|criteria_provided,_single_submitter|C0009405:Hereditary_nonpolyposis_colorectal_neoplasms|Invitae|None&Likely_pathogenic|2019-07-29|criteria_provided,_single_submitter|C3661900:not_provided|GeneDx|description:_Not_observed_in_large_population_cohorts_(Lek_et_al.,_2016)%3B_In_silico_analysis,_which_includes_protein_predictors_and_evolutionary_conservation,_supports_a_deleterious_effect%3B_This_variant_is_associated_with_the_following_publications:_(PMID:_24356096,_17531815,_30217226)&Likely_pathogenic|2021-02-05|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Ambry_Genetics|description:_The_p.F432L_variant_(also_known_as_c.1296T>G),_located_in_coding_exon_4_of_the_MSH6_gene,_results_from_a_T_to_G_substitution_at_nucleotide_position_1296._The_phenylalanine_at_codon_432_is_replaced_by_leucine,_an_amino_acid_with_highly_similar_properties._In_one_functional_study,_this_variant_demonstrated_deficient_mismatch_repair_activity_in_an_in_vitro_complementation_assay_(Drost_M_et_al._Genet_Med,_2020_05%3B22:847-856)._Based_on_internal_structural_assessment,_this_variant_impairs_formation_of_a_specific_interaction_with_mismatched_DNA_(Ambry_internal_data%3B_Warren_JJ_et_al._Mol_Cell,_2007_May%3B26:579-92)._This_variant_was_not_reported_in_population-based_cohorts_in_the_Genome_Aggregation_Database_(gnomAD)._This_amino_acid_position_is_highly_conserved_in_available_vertebrate_species._In_addition,_this_alteration_is_predicted_to_be_deleterious_by_in_silico_analysis._Based_on_the_majority_of_available_evidence_to_date,_this_variant_is_likely_to_be_pathogenic.;heredicare_annotation=13068850|0|0|14|CIMRA-Assay_Activity:_6.1,_posterior_P:0,991,_(Drost_et_al_Genetics_in_Medicine_2020_22_(5):_847-856)|2021-02-09;consequences=ENST00000234420|c.1296T>G|p.Phe432Leu|missense_variant|moderate|4|None|MSH6|PF01624|True|True|False|True|protein_coding|4073&ENST00000405808|c.169%2B8916A>C|None|intron_variant|modifier|None|3|FBXO11|None|True|False|False|False|protein_coding|170&ENST00000411819|None|None|downstream_gene_variant|modifier|None|None|MSH6|None|True|False|False|False|protein_coding|3777&ENST00000420813|None|None|downstream_gene_variant|modifier|None|None|MSH6|None|True|False|False|False|protein_coding|3777&ENST00000434234|c.*124%2B8715A>C|None|intron_variant_%26_NMD_transcript_variant|modifier|None|3|FBXO11|None|False|False|False|False|nonsense_mediated_decay|243&ENST00000444514|None|None|upstream_gene_variant|modifier|None|None|RPL36AP15|None|True|False|False|True|processed_pseudogene|265&ENST00000445503|c.*643T>G|None|3_prime_UTR_variant_%26_NMD_transcript_variant|modifier|3|None|MSH6|None|False|False|False|False|nonsense_mediated_decay|480&ENST00000455383|None|None|downstream_gene_variant|modifier|None|None|MSH6|None|True|False|False|False|protein_coding|3777&ENST00000456246|None|None|downstream_gene_variant|modifier|None|None|MSH6|None|False|False|False|False|nonsense_mediated_decay|313&ENST00000540021|c.906T>G|p.Phe302Leu|missense_variant|moderate|2|None|MSH6|PF01624|True|False|False|False|protein_coding|3685&ENST00000652107|c.999T>G|p.Phe333Leu|missense_variant|moderate|6|None|MSH6|PF01624|True|False|False|False|protein_coding|3777&ENST00000673637|c.999T>G|p.Phe333Leu|missense_variant|moderate|4|None|MSH6|PF01624|True|False|False|False|protein_coding|3777&ENST00000673922|None|None|downstream_gene_variant|modifier|None|None|MSH6|None|False|False|False|False|protein_coding_CDS_not_defined|571&ENST00000699999|n.1380T>G|None|non_coding_transcript_exon_variant|modifier|4|None|MSH6|None|False|False|False|False|retained_intron|4813&ENST00000700000|c.1296T>G|p.Phe432Leu|missense_variant|moderate|4|None|MSH6|PF01624|True|False|False|False|protein_coding|2507&ENST00000700001|None|None|downstream_gene_variant|modifier|None|None|MSH6|None|False|False|False|False|retained_intron|3056&ENST00000700002|c.1302T>G|p.Phe434Leu|missense_variant|moderate|4|None|MSH6|PF01624|True|False|False|False|protein_coding|4079&ENST00000700003|c.627%2B3216T>G|None|intron_variant_%26_NMD_transcript_variant|modifier|None|3|MSH6|None|False|False|False|False|nonsense_mediated_decay|686&ENST00000700004|c.453T>G|p.Phe151Leu|missense_variant|moderate|1|None|MSH6|PF01624|True|False|False|False|protein_coding|3691&ENST00000700005|None|None|upstream_gene_variant|modifier|None|None|MSH6|None|False|False|False|False|retained_intron|3062&ENST00000700006|None|None|upstream_gene_variant|modifier|None|None|MSH6|None|False|False|False|False|retained_intron|5228&ENST00000700007|None|None|upstream_gene_variant|modifier|None|None|MSH6|None|False|False|False|False|retained_intron|2745&ENST00000700008|None|None|upstream_gene_variant|modifier|None|None|MSH6|None|False|False|False|False|retained_intron|2397&ENST00000700009|None|None|upstream_gene_variant|modifier|None|None|MSH6|None|False|False|False|False|retained_intron|2808&ENST00000700010|None|None|upstream_gene_variant|modifier|None|None|MSH6|None|False|False|False|False|protein_coding_CDS_not_defined|1540&ENST00000700011|None|None|upstream_gene_variant|modifier|None|None|MSH6|None|False|False|False|False|retained_intron|3429&ENSR00000116860|None|None|regulatory_region_variant|modifier|None|None|None|None|False|False|False|False|None|None&NM_000179|c.1296T>G|p.Phe432Leu|missense_variant|moderate|4|None|MSH6|None|True|True|False|True|mRNA|4073&NM_001281492|c.906T>G|p.Phe302Leu|missense_variant|moderate|2|None|MSH6|None|True|False|False|False|mRNA|3685&NM_001281493|c.390T>G|p.Phe130Leu|missense_variant|moderate|3|None|MSH6|None|False|False|False|False|mRNA|3170&NM_001281494|c.390T>G|p.Phe130Leu|missense_variant|moderate|4|None|MSH6|None|False|False|False|False|mRNA|3170&XM_024452819|c.1296T>G|p.Phe432Leu|missense_variant|moderate|4|None|MSH6|None|False|False|False|False|None|None&XM_024452820|c.1113T>G|p.Phe371Leu|missense_variant|moderate|4|None|MSH6|None|False|False|False|False|None|None&XM_024452821|c.999T>G|p.Phe333Leu|missense_variant|moderate|4|None|MSH6|None|False|False|False|False|None|None&XM_024452822|c.390T>G|p.Phe130Leu|missense_variant|moderate|3|None|MSH6|None|False|False|False|False|None|None;literature=23621914&24933100
chr2	214730478	18964	CAT	C	.	.	phylop_100way=1.561;cadd_scaled=25.8;spliceai_details=BARD1%7C0.00%7C0.00%7C0.00%7C0.00%7C30%7C21%7C-15%7C5;spliceai_max_delta=0.0;maxentscan_swa=ENST00000260947$6.93%7C3.87%7C6.93%7C-2.98%7C-6.86%7C-2.98|ENST00000421162$6.93%7C3.87%7C6.93%7C-2.98%7C-6.86%7C-2.98|ENST00000613374$6.93%7C3.87%7C6.93%7C-2.98%7C-6.86%7C-2.98|ENST00000613706$6.93%7C3.87%7C6.93%7C-2.98%7C-6.86%7C-2.98|ENST00000617164$6.93%7C3.87%7C6.93%7C-2.98%7C-6.86%7C-2.98|ENST00000619009$6.93%7C3.87%7C6.93%7C-2.98%7C-6.86%7C-2.98|ENST00000620057$6.93%7C3.87%7C6.93%7C-2.98%7C-6.86%7C-2.98;gnomad_ac=1;gnomad_af=6.57324e-06;gnomad_hom=0;gnomad_het=1;gnomad_popmax=NFE;gnomad_popmax_AF=1.46990e-05;gnomad_popmax_AC=1;task_force_protein_domain=BRCT_Domains;task_force_protein_domain_source=PMID:_32726901;hexplorer=2.26;hexplorer_mut=-7.33;hexplorer_wt=-9.58;hexplorer_rev=-0.98;hexplorer_rev_mut=0.87;hexplorer_rev_wt=1.86;max_hbond=0.00;max_hbond_mut=3.00;max_hbond_wt=3.00;max_hbond_rev=0.00;max_hbond_rev_mut=11.10;max_hbond_rev_wt=11.10;heredicare_vid=11155822&16875374;clinvar=142499;rsid=587782504;cosmic=COSV104530919;clinvar_summary=criteria_provided,_multiple_submitters,_no_conflicts:Pathogenic/Likely_pathogenic;clinvar_submissions=Pathogenic|2020-01-15|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Color_Diagnostics,_LLC_DBA_Color_Health|description:_This_variant_deletes_2_nucleotides_in_exon_10_of_the_BARD1_gene,_creating_a_frameshift_and_premature_translation_stop_signal._This_variant_is_expected_to_result_in_an_absent_or_non-functional_protein_product._This_variant_has_been_identified_in_1/31408_chromosomes_in_the_general_population_by_the_Genome_Aggregation_Database_(gnomAD)._Loss_of_BARD1_function_is_a_known_mechanism_of_disease_(clinicalgenome.org)._Based_on_the_available_evidence,_this_variant_is_classified_as_Pathogenic.&Pathogenic|2022-09-21|criteria_provided,_single_submitter|C0346153:Familial_cancer_of_breast|Invitae|description:_This_sequence_change_creates_a_premature_translational_stop_signal_(p.Cys645*)_in_the_BARD1_gene._It_is_expected_to_result_in_an_absent_or_disrupted_protein_product._Loss-of-function_variants_in_BARD1_are_known_to_be_pathogenic_(PMID:_20077502,_21344236)._This_variant_is_present_in_population_databases_(rs587782504,_gnomAD_0.007%)._This_premature_translational_stop_signal_has_been_observed_in_individual(s)_with_family_history_of_breast_cancer_(PMID:_25452441,_26845104)._ClinVar_contains_an_entry_for_this_variant_(Variation_ID:_142499)._For_these_reasons,_this_variant_has_been_classified_as_Pathogenic.&Likely_pathogenic|2023-05-04|criteria_provided,_single_submitter|C3661900:not_provided|Institute_for_Clinical_Genetics,_University_Hospital_TU_Dresden,_University_Hospital_TU_Dresden|description:_PVS1,_PM2_SUP&Pathogenic|2014-06-10|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Ambry_Genetics|description:_Ã¢â‚¬â€¹<span_style%1Y"background-color:_initial%3B">The_c.1932_1933delAT_pathogenic_mutation,_located_in_exon_10_of_the_BARD1_gene,_results_from_a_deletion_of_2_nucleotides_between_positions_1932_and_1933,_causing_a_translational_frameshift_with_a_predicted_alternate_stop_codon._Since_frameshifts_are_typically_deleterious_in_nature,_this_alteration_is_interpreted_as_a_disease-causing_mutation_(ACMG_Recommendations_for_Standards_for_Interpretation_and_Reporting_of_Sequence_Variations._Revision_2007._Genet_Med._2008%3B10:294).&Pathogenic|2023-05-25|criteria_provided,_single_submitter|C0346153:Familial_cancer_of_breast|Myriad_Genetics,_Inc.|description:_This_variant_is_considered_pathogenic._This_variant_creates_a_termination_codon_and_is_predicted_to_result_in_premature_protein_truncation.&Likely_pathogenic|2022-12-05|criteria_provided,_single_submitter|C0006142:Malignant_tumor_of_breast|Women's_Health_and_Genetics/Laboratory_Corporation_of_America,_LabCorp|description:_Variant_summary:_BARD1_c.1932_1933delAT_(p.Cys645X)_results_in_a_premature_termination_codon,_predicted_to_cause_a_truncation_of_the_encoded_protein_or_absence_of_the_protein_due_to_nonsense_mediated_decay,_which_are_commonly_known_mechanisms_for_disease._Truncations_downstream_of_this_position_have_been_classified_as_pathogenic_by_our_laboratory._The_variant_allele_was_found_at_a_frequency_of_6.6e-06_in_150904_control_chromosomes_(gnomAD_v3.1.2)._c.1932_1933delAT_has_been_reported_in_the_literature_in_individuals_affected_with_breast_cancer_or_colorectal_cancer_(Couch_2015,_Shirt_2016,_AlDubayan_2018)._These_data_indicate_that_the_variant_may_be_associated_with_disease._To_our_knowledge,_no_experimental_evidence_demonstrating_an_impact_on_protein_function_has_been_reported._Five_ClinVar_submitters_have_assessed_the_variant_since_2014:_two_classified_the_variant_as_likely_pathogenic_and_three_as_pathogenic._Based_on_the_evidence_outlined_above,_the_variant_was_classified_as_likely_pathogenic.&Likely_pathogenic|2018-08-21|criteria_provided,_single_submitter|C3661900:not_provided|GeneDx|description:_This_deletion_of_two_nucleotides_is_denoted_BARD1_c.1932_1933delAT_at_the_cDNA_level_and_p.Cys645Ter_(C645X)_at_the_protein_level._The_normal_sequence,_with_the_bases_that_are_deleted_in_brackets,_is_AAGT[delAT]GTGA._The_deletion_creates_a_nonsense_variant,_which_changes_a_Cysteine_to_a_premature_stop_codon_(TGT>TGA),_and_is_predicted_to_cause_loss_of_normal_protein_function_through_either_protein_truncation_or_nonsense-mediated_mRNA_decay._BARD1_c.1932_1933delATAT_has_been_reported_in_an_individual_with_triple_negative_breast_cancer_and_in_an_individual_with_a_family_history_of_breast_cancer_(Couch_2015,_Shirts_2016)._This_variant_is_considered_likely_pathogenic.&Likely_pathogenic|2015-11-20|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|University_of_Washington_Department_of_Laboratory_Medicine,_University_of_Washington|None&Pathogenic|2022-06-03|criteria_provided,_single_submitter|C0346153:Familial_cancer_of_breast|MGZ_Medical_Genetics_Center|None&Likely_pathogenic|2023-09-19|criteria_provided,_single_submitter|C3661900:not_provided|Institute_of_Human_Genetics,_FAU_Erlangen,_Friedrich-Alexander-Universität_Erlangen-Nürnberg|description:_This_variant_has_been_identified_by_standard_clinical_testing._Selected_ACMG_criteria:_Likely_pathogenic_(I):PM2%3BPVS1;heredicare_annotation=11155822|2|2|15||2019-10-08&16875374|1|1|||;consequences=ENST00000260947|c.1932_1933del|p.Cys645Ter|frameshift_variant|high|10|None|BARD1|None|True|True|False|True|protein_coding|2323&ENST00000421162|c.579_580del|p.Cys194Ter|frameshift_variant|high|6|None|BARD1|None|True|False|False|False|protein_coding|974&ENST00000432456|c.29_30del|p.Cys11Ter|frameshift_variant|high|1|None|BARD1|None|False|False|False|False|protein_coding|132&ENST00000455743|c.*1552_*1553del|None|3_prime_UTR_variant_%26_NMD_transcript_variant|modifier|9|None|BARD1|None|False|False|False|False|nonsense_mediated_decay|228&ENST00000471590|n.267_268del|None|non_coding_transcript_exon_variant|modifier|2|None|BARD1|None|False|False|False|False|protein_coding_CDS_not_defined|918&ENST00000613192|c.187_188del|p.Met63ValfsTer69|frameshift_variant_%26_NMD_transcript_variant|high|2|None|BARD1|None|False|False|False|False|nonsense_mediated_decay|190&ENST00000613374|c.522_523del|p.Cys175Ter|frameshift_variant|high|5|None|BARD1|None|True|False|False|False|protein_coding|918&ENST00000613706|c.1524_1525del|p.Cys509Ter|frameshift_variant|high|10|None|BARD1|None|True|False|False|False|protein_coding|1915&ENST00000617164|c.1875_1876del|p.Cys626Ter|frameshift_variant|high|9|None|BARD1|None|True|False|False|False|protein_coding|2267&ENST00000619009|c.393_394del|p.Cys132Ter|frameshift_variant|high|4|None|BARD1|None|True|False|False|False|protein_coding|790&ENST00000620057|c.*598_*599del|None|3_prime_UTR_variant|modifier|9|None|BARD1|None|True|False|False|False|protein_coding|380&ENST00000650978|c.*2010_*2011del|None|3_prime_UTR_variant_%26_NMD_transcript_variant|modifier|9|None|BARD1|None|False|False|False|False|nonsense_mediated_decay|1293&ENSR00001044281|None|None|regulatory_region_variant|modifier|None|None|None|None|False|False|False|False|None|None&NM_000465|c.1932_1933del|p.Cys645Ter|frameshift_variant|high|10|None|BARD1|None|True|True|False|True|mRNA|2323&NM_001282543|c.1875_1876del|p.Cys626Ter|frameshift_variant|high|9|None|BARD1|None|True|False|False|False|mRNA|2267&NM_001282545|c.579_580del|p.Cys194Ter|frameshift_variant|high|6|None|BARD1|None|True|False|False|False|mRNA|974&NM_001282548|c.522_523del|p.Cys175Ter|frameshift_variant|high|5|None|BARD1|None|True|False|False|False|mRNA|918&NM_001282549|c.393_394del|p.Cys132Ter|frameshift_variant|high|4|None|BARD1|None|True|False|False|False|mRNA|790&NR_104212|n.1897_1898del|None|non_coding_transcript_exon_variant|modifier|9|None|BARD1|None|False|False|False|False|misc_RNA|5319&NR_104215|n.1840_1841del|None|non_coding_transcript_exon_variant|modifier|8|None|BARD1|None|False|False|False|False|misc_RNA|5263&NR_104216|n.1096_1097del|None|non_coding_transcript_exon_variant|modifier|9|None|BARD1|None|False|False|False|False|misc_RNA|4518&XM_017004613|c.2031_2032del|p.Cys678Ter|frameshift_variant|high|11|None|BARD1|None|False|False|False|False|mRNA|2421&XR_002959322|n.2122_2123del|None|non_coding_transcript_exon_variant|modifier|11|None|BARD1|None|False|False|False|False|None|None;literature=26845104&25452441&20077502&29478780&21344236&29292755&31589614&28569743
chr7	5982823	18193	C	T	.	.	phylop_100way=7.902;cadd_scaled=29.5;spliceai_details=PMS2%7C0.00%7C0.00%7C0.07%7C0.99%7C-5%7C35%7C-3%7C1;spliceai_max_delta=0.99;maxentscan_ref=8.201;maxentscan_alt=0.019;maxentscan=ENST00000265849$8.20%7C0.02|ENST00000382321$8.20%7C0.02|ENST00000642292$8.20%7C0.02|ENST00000642456$8.20%7C0.02|ENST00000699752$8.20%7C0.02|ENST00000699754$8.20%7C0.02|ENST00000699760$8.20%7C0.02|ENST00000699761$8.20%7C0.02|ENST00000699762$8.20%7C0.02|ENST00000699766$8.20%7C0.02|ENST00000699768$8.20%7C0.02|ENST00000699811$8.20%7C0.02|ENST00000699818$8.20%7C0.02|ENST00000699821$8.20%7C0.02|ENST00000699823$8.20%7C0.02|ENST00000699825$8.20%7C0.02|ENST00000699827$8.20%7C0.02|ENST00000699837$8.20%7C0.02|ENST00000699839$8.20%7C0.02|ENST00000699840$8.20%7C0.02|ENST00000699930$8.20%7C0.02;maxentscan_swa=ENST00000265849$8.20%7C0.02%7C8.20%7C-2.24%7C-3.51%7C-2.24|ENST00000382321$8.20%7C0.02%7C8.20%7C-2.24%7C-3.51%7C-2.24|ENST00000642292$8.20%7C0.02%7C8.20%7C-2.24%7C-3.51%7C-2.24|ENST00000642456$8.20%7C0.02%7C8.20%7C-2.24%7C-3.51%7C-2.24|ENST00000699752$8.20%7C0.02%7C8.20%7C-2.24%7C-3.51%7C-2.24|ENST00000699754$8.20%7C0.02%7C8.20%7C-2.24%7C-3.51%7C-2.24|ENST00000699760$8.20%7C0.02%7C8.20%7C-2.24%7C-3.51%7C-2.24|ENST00000699761$8.20%7C0.02%7C8.20%7C-2.24%7C-3.51%7C-2.24|ENST00000699762$8.20%7C0.02%7C8.20%7C-2.24%7C-3.51%7C-2.24|ENST00000699766$8.20%7C0.02%7C8.20%7C-2.24%7C-3.51%7C-2.24|ENST00000699768$8.20%7C0.02%7C8.20%7C-2.24%7C-3.51%7C-2.24|ENST00000699811$8.20%7C0.02%7C8.20%7C-2.24%7C-3.51%7C-2.24|ENST00000699818$8.20%7C0.02%7C8.20%7C-2.24%7C-3.51%7C-2.24|ENST00000699821$8.20%7C0.02%7C8.20%7C-2.24%7C-3.51%7C-2.24|ENST00000699823$8.20%7C0.02%7C8.20%7C-2.24%7C-3.51%7C-2.24|ENST00000699825$8.20%7C0.02%7C8.20%7C-2.24%7C-3.51%7C-2.24|ENST00000699827$8.20%7C0.02%7C8.20%7C-2.24%7C-3.51%7C-2.24|ENST00000699837$8.20%7C0.02%7C8.20%7C-2.24%7C-3.51%7C-2.24|ENST00000699839$8.20%7C0.02%7C8.20%7C-2.24%7C-3.51%7C-2.24|ENST00000699840$8.20%7C0.02%7C8.20%7C-2.24%7C-3.51%7C-2.24|ENST00000699930$8.20%7C0.02%7C8.20%7C-2.24%7C-3.51%7C-2.24|ENST00000699952$8.20%7C0.02%7C8.20%7C-2.24%7C-3.51%7C-2.24;gnomad_ac=2;gnomad_af=1.31893e-05;gnomad_hom=0;gnomad_het=2;gnomad_popmax=SAS;gnomad_popmax_AF=0.000207814;gnomad_popmax_AC=1;cancerhotspots_cancertypes=Diffuse_Large_B-Cell_Lymphoma:lymph%7CAdrenocortical_Carcinoma:adrenalgland;cancerhotspots_ac=2;cancerhotspots_af=8.251846350620951e-05;task_force_protein_domain=Dimerisation/MLH1_interaction;task_force_protein_domain_source=P54278_(P54278)_-_protein_-_InterPro_(ebi.ac.uk)%3B_PMID:_28765196%3B_InSiGHT-Richtlinien;hexplorer=-2.43;hexplorer_mut=0.56;hexplorer_wt=2.99;hexplorer_rev=-1.43;hexplorer_rev_mut=-3.20;hexplorer_rev_wt=-1.77;max_hbond_rev=-13.20;max_hbond_rev_wt=13.20;bayesdel=0.0597497;rsid=267608172;heredicare_vid=8082138;clinvar=91329;clinvar_summary=reviewed_by_expert_panel:Pathogenic;clinvar_submissions=Pathogenic|None|no_assertion_criteria_provided|C3661900:not_provided|Diagnostic_Laboratory,_Department_of_Genetics,_University_Medical_Center_Groningen|None&Pathogenic|2023-02-16|criteria_provided,_single_submitter|C3661900:not_provided|GeneDx|description:_Canonical_splice_site_variant_predicted_to_result_in_an_in-frame_deletion_of_a_critical_region%3B_Identified_in_the_heterozygous_state_in_patients_with_Lynch-related_cancers_(Senter_et_al.,_2008%3B_Vaughn_et_al.,_2010%3B_Yurgelun_et_al.,_2017%3B_Wang_et_al.,_2020%3B_Xu_et_al.,_2020)%3B_Published_functional_studies_demonstrate_a_damaging_effect:_aberrant_splicing_(Herkert_et_al.,_2011%3B_van_der_Klift_et_al.,_2015)%3B_Not_observed_at_a_significant_frequency_in_large_population_cohorts_(gnomAD)%3B_Truncating_variants_in_this_gene_are_considered_pathogenic_by_a_well-established_clinical_consortium_and/or_database%3B_This_variant_is_associated_with_the_following_publications:_(PMID:_25525159,_18602922,_20205264,_26247049,_26681312,_28726808,_28135145,_25186627,_30067863,_31992580,_33194656,_30787465,_33087929,_21376568)&Pathogenic|2014-03-14|reviewed_by_expert_panel|C4552100:Lynch_syndrome|International_Society_for_Gastrointestinal_Hereditary_Tumours_(InSiGHT)|description:_Interrupts_canonical_donor_splice_site&Pathogenic|2016-06-01|criteria_provided,_single_submitter|C1838333:Lynch_syndrome_4|Counsyl|None&Pathogenic|2022-03-21|criteria_provided,_single_submitter|CN221562:Breast_and/or_ovarian_cancer|CHEO_Genetics_Diagnostic_Laboratory,_Children's_Hospital_of_Eastern_Ontario|None&Pathogenic|2022-10-23|criteria_provided,_single_submitter|C0009405:Hereditary_nonpolyposis_colorectal_neoplasms|Invitae|description:_This_sequence_change_affects_a_donor_splice_site_in_intron_12_of_the_PMS2_gene._RNA_analysis_indicates_that_disruption_of_this_splice_site_induces_altered_splicing_and_likely_results_in_a_shortened_protein_product._The_frequency_data_for_this_variant_in_the_population_databases_(gnomAD)_is_considered_unreliable_due_to_the_presence_of_homologous_sequence,_such_as_pseudogenes_or_paralogs,_in_the_genome._Disruption_of_this_splice_site_has_been_observed_in_individuals_with_colorectal_cancer,_breast_cancer,_ovarian_cancer,_pancreatic_cancer,_suspected_Lynch_syndrome,_and_constitutional_mismatch_repair_deficiency_syndrome_(PMID:_18602922,_20205264,_21376568,_23012243,_25186627,_26110232,_26681312,_28135145,_30067863)._ClinVar_contains_an_entry_for_this_variant_(Variation_ID:_91329)._Studies_have_shown_that_disruption_of_this_splice_site_results_in_skipping_of_exon_12,_but_is_expected_to_preserve_the_integrity_of_the_reading-frame_(PMID:_21376568,_26247049)._This_variant_disrupts_the_MLH1_interaction_domain_of_the_PMS2_protein,_which_has_been_shown_to_be_critical_for_PMS2-MLH1_dimerization_(PMID:_10037723),_and_therefore_mismatch_repair_activity_(PMID:_16338176,_20533529)._While_functional_studies_have_not_been_performed_to_directly_test_the_effect_of_this_variant_on_PMS2_protein_function,_this_suggests_that_disruption_of_this_region_of_the_protein_is_causative_of_disease._For_these_reasons,_this_variant_has_been_classified_as_Pathogenic.&Likely_pathogenic|2023-04-05|criteria_provided,_single_submitter|C1838333:Lynch_syndrome_4|Myriad_Genetics,_Inc.|description:_This_variant_is_considered_likely_pathogenic._This_variant_occurs_within_a_consensus_splice_junction_and_is_predicted_to_result_in_abnormal_mRNA_splicing_of_either_an_out-of-frame_exon_or_an_in-frame_exon_necessary_for_protein_stability_and/or_normal_function.&Pathogenic|2018-05-21|criteria_provided,_single_submitter|C4552100:Lynch_syndrome|Women's_Health_and_Genetics/Laboratory_Corporation_of_America,_LabCorp|description:_Variant_summary:_PMS2_c.2174%2B1G>A_is_located_in_a_canonical_splice-site_and_is_predicted_to_affect_mRNA_splicing_resulting_in_a_significantly_altered_protein_due_to_either_exon_skipping,_shortening,_or_inclusion_of_intronic_material._Several_computational_tools_predict_a_significant_impact_on_normal_splicing:_Five_predict_the_variant_abolishes_a_5'_splicing_donor_site._At_least_one_publication_reports_experimental_evidence_that_this_variant_affects_mRNA_splicing._RNA_analysis_was_performed_to_study_the_effect_of_c.2174%2B1G>A_on_mRNA_splicing_and_to_confirm_that_this_mutation_is_located_in_PMS2_and_not_in_its_highly_homologous_pseudogene_PMS2CL._The_variant_allele_was_found_at_a_frequency_of_1.7e-05_in_239230_control_chromosomes._This_frequency_is_not_higher_than_expected_for_a_pathogenic_variant_in_PMS2_causing_Lynch_Syndrome_(1.7e-05_vs_0.00011),_allowing_no_conclusion_about_variant_significance._c.2174%2B1G>A_has_been_reported_in_the_literature_in_multiple_individuals_affected_with_Lynch_Syndrome_and_features_of_CMMRD._Specifically,_the_variant_has_been_cited_in_multiple_patients_in_both_heterozygous,_compound_heterozygous_(in_trans_with_a_second_pathogenic_PMS2_variant),_and_homozygous_state,_several_of_whom_have_loss_of_PMS2_via_IHC._Carrying_two_MMR_mutations_in_PMS2_in_trans_has_been_associated_with_constitutional_mismatch_repair-deficiency,_which_is_characterized_by_colonic_polyposis_and_hematologic,_brain_and_gastrointestinal_malignancies,_as_well_as_neurofribromas,_which_present_at_a_young_age_and_thus_both_mutations_may_be_explaining_the_phenotype_in_the_individuals_reported._The_variant_alone_was_found_in_unaffected_parents_of_probands,_further_supporting_the_idea_that_the_variant_is_involved_in_constitutional_mismatch_repair-deficiency._These_data_indicate_that_the_variant_is_very_likely_to_be_associated_with_disease._At_least_one_publication_reports_experimental_evidence_evaluating_an_impact_on_protein_function,_but_does_not_provide_convincing_conclusions_about_the_variant_effect._Five_clinical_diagnostic_laboratories_have_submitted_clinical-significance_assessments_for_this_variant_to_ClinVar_after_2014_and_all_laboratories_classified_the_variant_as_pathogenic._Based_on_the_evidence_outlined_above,_the_variant_was_classified_as_pathogenic.&Pathogenic|2016-11-01|criteria_provided,_single_submitter|C3661900:not_provided|CeGaT_Center_for_Human_Genetics_Tuebingen|None&not_provided|None|no_assertion_provided|C3661900:not_provided|MutSpliceDB:_a_database_of_splice_sites_variants_effects_on_splicing,_NIH|None&Pathogenic|2019-04-19|criteria_provided,_single_submitter|C4552100:Lynch_syndrome|Laboratory_for_Molecular_Medicine,_Mass_General_Brigham_Personalized_Medicine|description:_The_c.2174%2B1G>A_variant_in_PMS2_has_been_reported_in_1_heterozygous_individual_with_PMS2-associated_cancers,_and_in_1_compound_heterozygous_and_1_homozygous_individual_with_constitutional_mismatch_repair_deficiency_(Senter_2008,_Herkert_2011)._It_segregated_in_a_compound_heterozygous_state_with_disease_in_one_affect_sibling_(Herkert_2011)._It_has_also_has_been_identified_in_1/30070_of_South_Asian_chromosomes_by_gnomAD_(http://gnomad.broadinstitute.org)._This_variant_occurs_in_the_invariant_region_(%2B/-_1,2)_of_the_splice_consensus_sequence_and_is_predicted_to_cause_altered_splicing_leading_to_an_abnormal_or_absent_protein._In_vitro_functional_studies_provide_some_evidence_that_the_c.2174%2B1G>A_variant_may_impact_the_protein_(Van_Der_Klift,_2015)._In_addition,_it_was_classified_as_Pathogenic_on_April_16,_2014_by_the_ClinGen-approved_InSiGHT_Expert_Panel_(ClinVar_SCV000108333.3)._In_summary,_this_variant_meets_criteria_to_be_classified_as_pathogenic_for_Lynch_syndrome_in_an_autosomal_dominant_manner_based._ACMG/AMP_criteria_applied:_PM2,_PS4_Supporting,_PM3_Supporting,_PVS1.&Pathogenic|None|no_assertion_criteria_provided|C3661900:not_provided|Joint_Genome_Diagnostic_Labs_from_Nijmegen_and_Maastricht,_Radboudumc_and_MUMC%2B|None&Pathogenic|2021-12-10|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Ambry_Genetics|description:_The_c.2174%2B1G>A_intronic_pathogenic_mutation_results_from_a_G_to_A_substitution_one_nucleotide_after_coding_exon_12_of_the_PMS2_gene._Alterations_that_disrupt_the_canonical_splice_site_are_expected_to_result_in_aberrant_splicing._In_silico_splice_site_analysis_predicts_that_this_alteration_will_weaken_the_native_splice_donor_site._The_resulting_transcript_is_predicted_to_be_in-frame_and_is_not_expected_to_trigger_nonsense-mediated_mRNAdecay%3B_however,_direct_evidence_is_unavailable._The_exact_functional_effect_of_the_altered_amino_acid_sequence_is_unknown%3B_however,_the_impacted_region_is_critical_for_protein_function_(Ambry_internal_data)._A_splicing_minigene_assay_and_RNA_analysis_has_demonstrated_aberrant_splicing_(van_der_Klift_HM_et_al._Mol_Genet_Genomic_Med._2015_Jul%3B3(4):327-45)._This_mutation_has_been_detected_in_multiple_individuals_with_hereditary_non-polyposis_colorectal_cancer_(HNPCC)/Lynch_syndrome%3B_several_whose_tumors_demonstrated_loss_of_PMS2_by_immunohistochemistry_(IHC)_(Senter_L_et_al._Gastroenterology._2008_Aug%3B135(2):419-28%3B_Yurgelun_MB_et_al._J_Clin_Oncol._2017_Apr_1%3B35(10):1086-1095%3B_Brand_R_et_al._Cancer,_2018_09%3B124:3520-3527%3B_Wang_Q_et_al._J_Med_Genet,_2020_07%3B57:487-499)._This_mutation_has_also_been_detected_in_the_homozygous_and_compound_heterozygous_state_in_multiple_patients_with_constitutional_mismatch_repair_deficiency_(CMMR-D)_syndrome_(Vaughn_CP_et_al._Hum_Mutat._2010_May%3B31(5):588-93%3B_Herkert_JC_et_al._Eur._J._Cancer._2011_May%3B47(7):965-82)._Based_on_the_supporting_evidence,_this_alteration_is_interpreted_as_a_disease-causing_mutation.;heredicare_annotation=8082138|0|0|15|1._Senter_(2008)_Gastroenterology_135:_419_PubMed:_18602922%3BNo_comments_2._Herkert_(2011)_Eur_J_Cancer_47:_965_PubMed:_21376568%3BMMR_deficiency|2017-02-09;consequences=ENST00000265849|c.2174%2B1G>A|None|splice_donor_variant|high|None|12|PMS2|None|True|True|False|True|protein_coding|2574&ENST00000382321|c.971%2B1G>A|None|splice_donor_variant|high|None|8|PMS2|None|True|False|False|False|protein_coding|1375&ENST00000406569|c.1678%2B4264G>A|None|intron_variant_%26_NMD_transcript_variant|modifier|None|11|PMS2|None|False|False|False|False|nonsense_mediated_decay|1707&ENST00000469652|None|None|downstream_gene_variant|modifier|None|None|PMS2|None|False|False|False|False|protein_coding_CDS_not_defined|90&ENST00000642292|c.1769%2B1G>A|None|splice_donor_variant|high|None|11|PMS2|None|True|False|False|False|protein_coding|2173&ENST00000642456|c.1769%2B1G>A|None|splice_donor_variant|high|None|12|PMS2|None|True|False|False|False|protein_coding|2173&ENST00000643595|c.*1573%2B1G>A|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|12|PMS2|None|False|False|False|False|nonsense_mediated_decay|546&ENST00000644110|c.*1768%2B1G>A|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|11|PMS2|None|False|False|False|False|nonsense_mediated_decay|299&ENST00000699752|c.2018%2B1G>A|None|splice_donor_variant|high|None|11|PMS2|None|True|False|False|False|protein_coding|2419&ENST00000699753|c.*1595%2B1G>A|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|12|PMS2|None|False|False|False|False|nonsense_mediated_decay|142&ENST00000699754|c.1976%2B1G>A|None|splice_donor_variant|high|None|10|PMS2|None|True|False|False|False|protein_coding|2378&ENST00000699755|c.*1573%2B1G>A|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|12|PMS2|None|False|False|False|False|nonsense_mediated_decay|145&ENST00000699756|c.*1761%2B1G>A|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|12|PMS2|None|False|False|False|False|nonsense_mediated_decay|355&ENST00000699757|c.*1431%2B1G>A|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|10|PMS2|None|False|False|False|False|nonsense_mediated_decay|189&ENST00000699758|c.*1431%2B1G>A|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|10|PMS2|None|False|False|False|False|nonsense_mediated_decay|451&ENST00000699759|n.3028%2B1G>A|None|splice_donor_variant_%26_non_coding_transcript_variant|high|None|14|PMS2|None|False|False|False|False|protein_coding_CDS_not_defined|5870&ENST00000699760|c.1856%2B1G>A|None|splice_donor_variant|high|None|10|PMS2|None|True|False|False|False|protein_coding|2259&ENST00000699761|c.1769%2B1G>A|None|splice_donor_variant|high|None|12|PMS2|None|True|False|False|False|protein_coding|2173&ENST00000699762|c.1601%2B1G>A|None|splice_donor_variant|high|None|11|PMS2|None|True|False|False|False|protein_coding|2006&ENST00000699763|c.*1264%2B1G>A|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|13|PMS2|None|False|False|False|False|nonsense_mediated_decay|621&ENST00000699764|c.*492%2B1G>A|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|13|PMS2|None|False|False|False|False|nonsense_mediated_decay|1581&ENST00000699765|c.*1270%2B1G>A|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|10|PMS2|None|False|False|False|False|nonsense_mediated_decay|481&ENST00000699766|c.2174%2B1G>A|None|splice_donor_variant|high|None|12|PMS2|None|True|False|False|False|protein_coding|2607&ENST00000699767|c.2174%2B1G>A|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|12|PMS2|None|False|False|False|False|nonsense_mediated_decay|2302&ENST00000699768|c.2174%2B1G>A|None|splice_donor_variant|high|None|12|PMS2|None|True|False|False|False|protein_coding|2431&ENST00000699811|c.1769%2B1G>A|None|splice_donor_variant|high|None|12|PMS2|None|True|False|False|False|protein_coding|2173&ENST00000699813|n.2287%2B1G>A|None|splice_donor_variant_%26_non_coding_transcript_variant|high|None|8|PMS2|None|False|False|False|False|retained_intron|5135&ENST00000699814|c.*1570%2B1G>A|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|8|PMS2|None|False|False|False|False|nonsense_mediated_decay|299&ENST00000699815|c.*1705%2B1G>A|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|13|PMS2|None|False|False|False|False|nonsense_mediated_decay|217&ENST00000699816|c.*1064%2B1G>A|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|13|PMS2|None|False|False|False|False|nonsense_mediated_decay|737&ENST00000699817|c.*1768%2B1G>A|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|10|PMS2|None|False|False|False|False|nonsense_mediated_decay|213&ENST00000699818|c.1769%2B1G>A|None|splice_donor_variant|high|None|12|PMS2|None|True|False|False|False|protein_coding|2173&ENST00000699819|c.*1331%2B1G>A|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|11|PMS2|None|False|False|False|False|nonsense_mediated_decay|273&ENST00000699820|c.*112%2B1G>A|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|11|PMS2|None|False|False|False|False|nonsense_mediated_decay|1189&ENST00000699821|c.1769%2B1G>A|None|splice_donor_variant|high|None|12|PMS2|None|True|False|False|False|protein_coding|2206&ENST00000699822|c.*1626%2B1G>A|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|13|PMS2|None|False|False|False|False|nonsense_mediated_decay|217&ENST00000699823|c.1769%2B1G>A|None|splice_donor_variant|high|None|11|PMS2|None|True|False|False|False|protein_coding|2173&ENST00000699824|c.*1677%2B1G>A|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|13|PMS2|None|False|False|False|False|nonsense_mediated_decay|618&ENST00000699825|c.1613%2B1G>A|None|splice_donor_variant|high|None|11|PMS2|None|True|False|False|False|protein_coding|2018&ENST00000699826|c.*1573%2B1G>A|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|11|PMS2|None|False|False|False|False|nonsense_mediated_decay|145&ENST00000699827|c.2006%2B1G>A|None|splice_donor_variant|high|None|11|PMS2|None|True|False|False|False|protein_coding|2407&ENST00000699828|c.*1264%2B1G>A|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|13|PMS2|None|False|False|False|False|nonsense_mediated_decay|1022&ENST00000699829|None|None|downstream_gene_variant|modifier|None|None|PMS2|None|False|False|False|False|nonsense_mediated_decay|217&ENST00000699830|None|None|downstream_gene_variant|modifier|None|None|PMS2|None|False|False|False|False|nonsense_mediated_decay|543&ENST00000699833|n.3946%2B1G>A|None|splice_donor_variant_%26_non_coding_transcript_variant|high|None|11|PMS2|None|False|False|False|False|retained_intron|6791&ENST00000699837|c.1769%2B1G>A|None|splice_donor_variant|high|None|11|PMS2|None|True|False|False|False|protein_coding|2173&ENST00000699838|c.*2074%2B1G>A|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|13|PMS2|None|False|False|False|False|nonsense_mediated_decay|264&ENST00000699839|c.2360%2B1G>A|None|splice_donor_variant|high|None|13|PMS2|None|True|False|False|False|protein_coding|2759&ENST00000699840|None|None|downstream_gene_variant|modifier|None|None|PMS2|None|True|False|False|False|protein_coding|2571&ENST00000699916|c.*1431%2B1G>A|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|12|PMS2|None|False|False|False|False|nonsense_mediated_decay|288&ENST00000699917|c.*1623%2B1G>A|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|13|PMS2|None|False|False|False|False|nonsense_mediated_decay|618&ENST00000699918|c.*1675%2B1G>A|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|13|PMS2|None|False|False|False|False|nonsense_mediated_decay|618&ENST00000699919|c.*1761%2B1G>A|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|13|PMS2|None|False|False|False|False|nonsense_mediated_decay|618&ENST00000699920|c.*1810%2B1G>A|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|13|PMS2|None|False|False|False|False|nonsense_mediated_decay|618&ENST00000699928|c.*112%2B1G>A|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|10|PMS2|None|False|False|False|False|nonsense_mediated_decay|1034&ENST00000699929|None|None|downstream_gene_variant|modifier|None|None|PMS2|None|False|False|False|False|nonsense_mediated_decay|546&ENST00000699930|None|None|downstream_gene_variant|modifier|None|None|PMS2|None|True|False|False|False|protein_coding|2466&ENST00000699931|None|None|downstream_gene_variant|modifier|None|None|PMS2|None|False|False|False|False|protein_coding_CDS_not_defined|3240&ENST00000699932|None|None|downstream_gene_variant|modifier|None|None|PMS2|None|False|False|False|False|nonsense_mediated_decay|796&ENST00000699951|c.*1270%2B1G>A|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|11|PMS2|None|False|False|False|False|nonsense_mediated_decay|796&ENST00000699952|c.*-9281G>A|None|intron_variant|modifier|None|7|PMS2|None|True|False|False|False|protein_coding|796&ENST00000699953|None|None|downstream_gene_variant|modifier|None|None|PMS2|None|False|False|False|False|nonsense_mediated_decay|788&ENST00000699954|None|None|downstream_gene_variant|modifier|None|None|PMS2|None|False|False|False|False|nonsense_mediated_decay|543&NM_000535|c.2174%2B1G>A|None|splice_donor_variant|high|None|12|PMS2|None|True|True|False|True|mRNA|2574&NM_001322003|c.1769%2B1G>A|None|splice_donor_variant|high|None|12|PMS2|None|True|False|False|False|mRNA|2173&NM_001322004|c.1769%2B1G>A|None|splice_donor_variant|high|None|11|PMS2|None|True|False|False|False|mRNA|2173&NM_001322005|c.1769%2B1G>A|None|splice_donor_variant|high|None|12|PMS2|None|True|False|False|False|mRNA|2173&NM_001322006|c.2018%2B1G>A|None|splice_donor_variant|high|None|11|PMS2|None|False|False|False|False|mRNA|2419&NM_001322007|c.1856%2B1G>A|None|splice_donor_variant|high|None|11|PMS2|None|False|False|False|False|mRNA|2259&NM_001322008|c.1856%2B1G>A|None|splice_donor_variant|high|None|10|PMS2|None|False|False|False|False|mRNA|2259&NM_001322009|c.1769%2B1G>A|None|splice_donor_variant|high|None|12|PMS2|None|False|False|False|False|mRNA|2206&NM_001322010|c.1613%2B1G>A|None|splice_donor_variant|high|None|10|PMS2|None|False|False|False|False|mRNA|2018&NM_001322011|c.1241%2B1G>A|None|splice_donor_variant|high|None|12|PMS2|None|False|False|False|False|mRNA|1649&NM_001322012|c.1241%2B1G>A|None|splice_donor_variant|high|None|12|PMS2|None|False|False|False|False|mRNA|1649&NM_001322013|c.1601%2B1G>A|None|splice_donor_variant|high|None|11|PMS2|None|False|False|False|False|mRNA|2006&NM_001322014|c.2174%2B1G>A|None|splice_donor_variant|high|None|12|PMS2|None|False|False|False|False|mRNA|2607&NM_001322015|c.1865%2B1G>A|None|splice_donor_variant|high|None|12|PMS2|None|False|False|False|False|mRNA|2269&NR_136154|n.2261%2B1G>A|None|splice_donor_variant_%26_non_coding_transcript_variant|high|None|12|PMS2|None|False|False|False|False|misc_RNA|5092&XM_006715744|c.1241%2B1G>A|None|splice_donor_variant|high|None|5|PMS2|None|False|False|False|False|None|None&XM_017012342|c.1241%2B1G>A|None|splice_donor_variant|high|None|11|PMS2|None|False|False|False|False|None|None&XM_024446800|c.1613%2B1G>A|None|splice_donor_variant|high|None|11|PMS2|None|False|False|False|False|mRNA|2018;literature=24033266&25525159&25980754&25186627&26681312&26247049&24362816&18602922&21376568&20205264&26110232&25790293&23012243&16199547&28135145&30067863&27435373&29308099&34994648&36291559&30787465&34873870&35260767
